{
    "medicine_id": "025305216b6d41e651a251b8ea4d4ccc97b2369c",
    "platform_id": "DB06691",
    "metadata": {
        "name": "A Tan 12X Suspension 500 mg 100g Cream",
        "composition": "500 mg 100g Mepyramine",
        "clinical_particulars": {
            "therapeutic_indications": "Indicated for the treatment of allergic conditions symptomatic relief of hypersensitivity reaction and treatment of pruritic skin disorders",
            "contraindications": {
                "disease": "The signs and symptoms that are produced after the acute overdosage of Mepyramine include Convulsions Coma Ataxia Hyperpyrexia Tremor Extrapyramidal effects Excitement",
                "pregnancy": "NA",
                "machine_ops": "NA",
                "pharmacodynamics": "NA",
                "excipients": "NA",
                "incompatibilities": [
                    {
                        "drugbank-id": "DB00921",
                        "description": "Mepyramine may increase the central nervous system depressant CNS depressant activities of Buprenorphine"
                    },
                    {
                        "drugbank-id": "DB00366",
                        "description": "Doxylamine may increase the central nervous system depressant CNS depressant activities of Mepyramine"
                    },
                    {
                        "drugbank-id": "DB00470",
                        "description": "Dronabinol may increase the central nervous system depressant CNS depressant activities of Mepyramine"
                    },
                    {
                        "drugbank-id": "DB00450",
                        "description": "Droperidol may increase the central nervous system depressant CNS depressant activities of Mepyramine"
                    },
                    {
                        "drugbank-id": "DB00653",
                        "description": "The therapeutic efficacy of Mepyramine can be increased when used in combination with Magnesium sulfate"
                    },
                    {
                        "drugbank-id": "DB01403",
                        "description": "Mepyramine may increase the central nervous system depressant CNS depressant activities of Methotrimeprazine"
                    },
                    {
                        "drugbank-id": "DB00765",
                        "description": "Mepyramine may increase the sedative activities of Metyrosine"
                    },
                    {
                        "drugbank-id": "DB01017",
                        "description": "Minocycline may increase the central nervous system depressant CNS depressant activities of Mepyramine"
                    },
                    {
                        "drugbank-id": "DB00370",
                        "description": "Mepyramine may increase the central nervous system depressant CNS depressant activities of Mirtazapine"
                    },
                    {
                        "drugbank-id": "DB00486",
                        "description": "Nabilone may increase the central nervous system depressant CNS depressant activities of Mepyramine"
                    },
                    {
                        "drugbank-id": "DB01173",
                        "description": "Mepyramine may increase the central nervous system depressant CNS depressant activities of Orphenadrine"
                    },
                    {
                        "drugbank-id": "DB09117",
                        "description": "Mepyramine may increase the central nervous system depressant CNS depressant activities of Paraldehyde"
                    },
                    {
                        "drugbank-id": "DB08883",
                        "description": "Perampanel may increase the central nervous system depressant CNS depressant activities of Mepyramine"
                    },
                    {
                        "drugbank-id": "DB00413",
                        "description": "Mepyramine may increase the sedative activities of Pramipexole"
                    },
                    {
                        "drugbank-id": "DB00268",
                        "description": "Mepyramine may increase the sedative activities of Ropinirole"
                    },
                    {
                        "drugbank-id": "DB05271",
                        "description": "Mepyramine may increase the sedative activities of Rotigotine"
                    },
                    {
                        "drugbank-id": "DB06201",
                        "description": "The risk or severity of adverse effects can be increased when Rufinamide is combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB09034",
                        "description": "Mepyramine may increase the central nervous system depressant CNS depressant activities of Suvorexant"
                    },
                    {
                        "drugbank-id": "DB06204",
                        "description": "Tapentadol may increase the central nervous system depressant CNS depressant activities of Mepyramine"
                    },
                    {
                        "drugbank-id": "DB01041",
                        "description": "Mepyramine may increase the central nervous system depressant CNS depressant activities of Thalidomide"
                    },
                    {
                        "drugbank-id": "DB00425",
                        "description": "Mepyramine may increase the central nervous system depressant CNS depressant activities of Zolpidem"
                    },
                    {
                        "drugbank-id": "DB00895",
                        "description": "Mepyramine may decrease effectiveness of Benzylpenicilloyl polylysine as a diagnostic agent"
                    },
                    {
                        "drugbank-id": "DB06698",
                        "description": "The therapeutic efficacy of Betahistine can be decreased when used in combination with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB00333",
                        "description": "The risk or severity of adverse effects can be increased when Methadone is combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB09072",
                        "description": "Mepyramine may increase the central nervous system depressant CNS depressant activities of Sodium oxybate"
                    },
                    {
                        "drugbank-id": "DB00289",
                        "description": "The metabolism of Atomoxetine can be decreased when combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB00898",
                        "description": "Mepyramine may increase the central nervous system depressant CNS depressant activities of Ethanol"
                    },
                    {
                        "drugbank-id": "DB00972",
                        "description": "Mepyramine may increase the central nervous system depressant CNS depressant activities of Azelastine"
                    },
                    {
                        "drugbank-id": "DB00484",
                        "description": "Brimonidine may increase the central nervous system depressant CNS depressant activities of Mepyramine"
                    },
                    {
                        "drugbank-id": "DB01105",
                        "description": "The risk or severity of adverse effects can be increased when Mepyramine is combined with Sibutramine"
                    },
                    {
                        "drugbank-id": "DB04832",
                        "description": "The risk or severity of adverse effects can be increased when Mepyramine is combined with Zimelidine"
                    },
                    {
                        "drugbank-id": "DB04896",
                        "description": "The risk or severity of adverse effects can be increased when Mepyramine is combined with Milnacipran"
                    },
                    {
                        "drugbank-id": "DB06700",
                        "description": "The risk or severity of adverse effects can be increased when Mepyramine is combined with Desvenlafaxine"
                    },
                    {
                        "drugbank-id": "DB06731",
                        "description": "The risk or severity of adverse effects can be increased when Mepyramine is combined with Seproxetine"
                    },
                    {
                        "drugbank-id": "DB08953",
                        "description": "The risk or severity of adverse effects can be increased when Mepyramine is combined with Indalpine"
                    },
                    {
                        "drugbank-id": "DB12693",
                        "description": "The risk or severity of adverse effects can be increased when Mepyramine is combined with Ritanserin"
                    },
                    {
                        "drugbank-id": "DB13233",
                        "description": "The risk or severity of adverse effects can be increased when Mepyramine is combined with Alaproclate"
                    },
                    {
                        "drugbank-id": "DB00176",
                        "description": "The risk or severity of adverse effects can be increased when Mepyramine is combined with Fluvoxamine"
                    },
                    {
                        "drugbank-id": "DB00215",
                        "description": "The risk or severity of adverse effects can be increased when Mepyramine is combined with Citalopram"
                    },
                    {
                        "drugbank-id": "DB00476",
                        "description": "The risk or severity of adverse effects can be increased when Mepyramine is combined with Duloxetine"
                    },
                    {
                        "drugbank-id": "DB00715",
                        "description": "The risk or severity of adverse effects can be increased when Mepyramine is combined with Paroxetine"
                    },
                    {
                        "drugbank-id": "DB01104",
                        "description": "The risk or severity of adverse effects can be increased when Mepyramine is combined with Sertraline"
                    },
                    {
                        "drugbank-id": "DB01149",
                        "description": "The risk or severity of adverse effects can be increased when Mepyramine is combined with Nefazodone"
                    },
                    {
                        "drugbank-id": "DB01175",
                        "description": "The risk or severity of adverse effects can be increased when Mepyramine is combined with Escitalopram"
                    },
                    {
                        "drugbank-id": "DB04884",
                        "description": "The risk or severity of adverse effects can be increased when Mepyramine is combined with Dapoxetine"
                    },
                    {
                        "drugbank-id": "DB08918",
                        "description": "The risk or severity of adverse effects can be increased when Mepyramine is combined with Levomilnacipran"
                    },
                    {
                        "drugbank-id": "DB00182",
                        "description": "Amphetamine may decrease the sedative and stimulatory activities of Mepyramine"
                    },
                    {
                        "drugbank-id": "DB00191",
                        "description": "Phentermine may decrease the sedative and stimulatory activities of Mepyramine"
                    },
                    {
                        "drugbank-id": "DB00865",
                        "description": "Benzphetamine may decrease the sedative and stimulatory activities of Mepyramine"
                    },
                    {
                        "drugbank-id": "DB00937",
                        "description": "Diethylpropion may decrease the sedative and stimulatory activities of Mepyramine"
                    },
                    {
                        "drugbank-id": "DB01255",
                        "description": "Lisdexamfetamine may decrease the sedative and stimulatory activities of Mepyramine"
                    },
                    {
                        "drugbank-id": "DB01365",
                        "description": "Mephentermine may decrease the sedative and stimulatory activities of Mepyramine"
                    },
                    {
                        "drugbank-id": "DB01442",
                        "description": "MMDA may decrease the sedative and stimulatory activities of Mepyramine"
                    },
                    {
                        "drugbank-id": "DB01454",
                        "description": "Midomafetamine may decrease the sedative and stimulatory activities of Mepyramine"
                    },
                    {
                        "drugbank-id": "DB01467",
                        "description": "2 5 Dimethoxy 4 ethylamphetamine may decrease the sedative and stimulatory activities of Mepyramine"
                    },
                    {
                        "drugbank-id": "DB01484",
                        "description": "4 Bromo 2 5 dimethoxyamphetamine may decrease the sedative and stimulatory activities of Mepyramine"
                    },
                    {
                        "drugbank-id": "DB01509",
                        "description": "Tenamfetamine may decrease the sedative and stimulatory activities of Mepyramine"
                    },
                    {
                        "drugbank-id": "DB01556",
                        "description": "Chlorphentermine may decrease the sedative and stimulatory activities of Mepyramine"
                    },
                    {
                        "drugbank-id": "DB01566",
                        "description": "Methylenedioxyethamphetamine may decrease the sedative and stimulatory activities of Mepyramine"
                    },
                    {
                        "drugbank-id": "DB01576",
                        "description": "Dextroamphetamine may decrease the sedative and stimulatory activities of Mepyramine"
                    },
                    {
                        "drugbank-id": "DB01577",
                        "description": "Metamfetamine may decrease the sedative and stimulatory activities of Mepyramine"
                    },
                    {
                        "drugbank-id": "DB09480",
                        "description": "Iofetamine I 123 may decrease the sedative and stimulatory activities of Mepyramine"
                    },
                    {
                        "drugbank-id": "DB12080",
                        "description": "Ritobegron may decrease the sedative and stimulatory activities of Mepyramine"
                    },
                    {
                        "drugbank-id": "DB13108",
                        "description": "Mephedrone may decrease the sedative and stimulatory activities of Mepyramine"
                    },
                    {
                        "drugbank-id": "DB13624",
                        "description": "Methoxyphenamine may decrease the sedative and stimulatory activities of Mepyramine"
                    },
                    {
                        "drugbank-id": "DB13703",
                        "description": "Gepefrine may decrease the sedative and stimulatory activities of Mepyramine"
                    },
                    {
                        "drugbank-id": "DB13940",
                        "description": "2 5 Dimethoxy 4 ethylthioamphetamine may decrease the sedative and stimulatory activities of Mepyramine"
                    },
                    {
                        "drugbank-id": "DB00209",
                        "description": "Mepyramine may increase the central nervous system depressant CNS depressant activities of Trospium"
                    },
                    {
                        "drugbank-id": "DB00219",
                        "description": "Mepyramine may increase the central nervous system depressant CNS depressant activities of Oxyphenonium"
                    },
                    {
                        "drugbank-id": "DB00332",
                        "description": "Mepyramine may increase the central nervous system depressant CNS depressant activities of Ipratropium"
                    },
                    {
                        "drugbank-id": "DB00340",
                        "description": "Mepyramine may increase the central nervous system depressant CNS depressant activities of Metixene"
                    },
                    {
                        "drugbank-id": "DB00354",
                        "description": "Mepyramine may increase the central nervous system depressant CNS depressant activities of Buclizine"
                    },
                    {
                        "drugbank-id": "DB00376",
                        "description": "Mepyramine may increase the central nervous system depressant CNS depressant activities of Trihexyphenidyl"
                    },
                    {
                        "drugbank-id": "DB00383",
                        "description": "Mepyramine may increase the central nervous system depressant CNS depressant activities of Oxyphencyclimine"
                    },
                    {
                        "drugbank-id": "DB00387",
                        "description": "Mepyramine may increase the central nervous system depressant CNS depressant activities of Procyclidine"
                    },
                    {
                        "drugbank-id": "DB00392",
                        "description": "Mepyramine may increase the central nervous system depressant CNS depressant activities of Profenamine"
                    },
                    {
                        "drugbank-id": "DB00424",
                        "description": "Mepyramine may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB00434",
                        "description": "Mepyramine may increase the central nervous system depressant CNS depressant activities of Cyproheptadine"
                    },
                    {
                        "drugbank-id": "DB00462",
                        "description": "Mepyramine may increase the central nervous system depressant CNS depressant activities of Methscopolamine bromide"
                    },
                    {
                        "drugbank-id": "DB00483",
                        "description": "Mepyramine may increase the central nervous system depressant CNS depressant activities of Gallamine triethiodide"
                    },
                    {
                        "drugbank-id": "DB00505",
                        "description": "Mepyramine may increase the central nervous system depressant CNS depressant activities of Tridihexethyl"
                    },
                    {
                        "drugbank-id": "DB00508",
                        "description": "Mepyramine may increase the central nervous system depressant CNS depressant activities of Triflupromazine"
                    },
                    {
                        "drugbank-id": "DB00517",
                        "description": "Mepyramine may increase the central nervous system depressant CNS depressant activities of Anisotropine methylbromide"
                    },
                    {
                        "drugbank-id": "DB00555",
                        "description": "Mepyramine may increase the central nervous system depressant CNS depressant activities of Lamotrigine"
                    },
                    {
                        "drugbank-id": "DB00622",
                        "description": "Mepyramine may increase the central nervous system depressant CNS depressant activities of Nicardipine"
                    },
                    {
                        "drugbank-id": "DB00670",
                        "description": "Mepyramine may increase the central nervous system depressant CNS depressant activities of Pirenzepine"
                    },
                    {
                        "drugbank-id": "DB00725",
                        "description": "Mepyramine may increase the central nervous system depressant CNS depressant activities of Homatropine methylbromide"
                    },
                    {
                        "drugbank-id": "DB00728",
                        "description": "Mepyramine may increase the central nervous system depressant CNS depressant activities of Rocuronium"
                    },
                    {
                        "drugbank-id": "DB00747",
                        "description": "Mepyramine may increase the central nervous system depressant CNS depressant activities of Scopolamine"
                    },
                    {
                        "drugbank-id": "DB00767",
                        "description": "Mepyramine may increase the central nervous system depressant CNS depressant activities of Benzquinamide"
                    },
                    {
                        "drugbank-id": "DB00771",
                        "description": "Mepyramine may increase the central nervous system depressant CNS depressant activities of Clidinium"
                    },
                    {
                        "drugbank-id": "DB00777",
                        "description": "Mepyramine may increase the central nervous system depressant CNS depressant activities of Propiomazine"
                    },
                    {
                        "drugbank-id": "DB00782",
                        "description": "Mepyramine may increase the central nervous system depressant CNS depressant activities of Propantheline"
                    },
                    {
                        "drugbank-id": "DB00804",
                        "description": "Mepyramine may increase the central nervous system depressant CNS depressant activities of Dicyclomine"
                    },
                    {
                        "drugbank-id": "DB00810",
                        "description": "Mepyramine may increase the central nervous system depressant CNS depressant activities of Biperiden"
                    },
                    {
                        "drugbank-id": "DB00835",
                        "description": "Mepyramine may increase the central nervous system depressant CNS depressant activities of Brompheniramine"
                    },
                    {
                        "drugbank-id": "DB00940",
                        "description": "Mepyramine may increase the central nervous system depressant CNS depressant activities of Methantheline"
                    },
                    {
                        "drugbank-id": "DB00942",
                        "description": "Mepyramine may increase the central nervous system depressant CNS depressant activities of Cycrimine"
                    },
                    {
                        "drugbank-id": "DB00986",
                        "description": "Mepyramine may increase the central nervous system depressant CNS depressant activities of Glycopyrronium"
                    },
                    {
                        "drugbank-id": "DB01062",
                        "description": "Mepyramine may increase the central nervous system depressant CNS depressant activities of Oxybutynin"
                    },
                    {
                        "drugbank-id": "DB01135",
                        "description": "Mepyramine may increase the central nervous system depressant CNS depressant activities of Doxacurium"
                    },
                    {
                        "drugbank-id": "DB01148",
                        "description": "Mepyramine may increase the central nervous system depressant CNS depressant activities of Flavoxate"
                    },
                    {
                        "drugbank-id": "DB01226",
                        "description": "Mepyramine may increase the central nervous system depressant CNS depressant activities of Mivacurium"
                    },
                    {
                        "drugbank-id": "DB01231",
                        "description": "Mepyramine may increase the central nervous system depressant CNS depressant activities of Diphenidol"
                    },
                    {
                        "drugbank-id": "DB01239",
                        "description": "Mepyramine may increase the central nervous system depressant CNS depressant activities of Chlorprothixene"
                    },
                    {
                        "drugbank-id": "DB01336",
                        "description": "Mepyramine may increase the central nervous system depressant CNS depressant activities of Metocurine"
                    },
                    {
                        "drugbank-id": "DB01337",
                        "description": "Mepyramine may increase the central nervous system depressant CNS depressant activities of Pancuronium"
                    },
                    {
                        "drugbank-id": "DB01338",
                        "description": "Mepyramine may increase the central nervous system depressant CNS depressant activities of Pipecuronium"
                    },
                    {
                        "drugbank-id": "DB01625",
                        "description": "Mepyramine may increase the central nervous system depressant CNS depressant activities of Isopropamide"
                    },
                    {
                        "drugbank-id": "DB04834",
                        "description": "Mepyramine may increase the central nervous system depressant CNS depressant activities of Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB04843",
                        "description": "Mepyramine may increase the central nervous system depressant CNS depressant activities of Mepenzolate"
                    },
                    {
                        "drugbank-id": "DB06153",
                        "description": "Mepyramine may increase the central nervous system depressant CNS depressant activities of Pizotifen"
                    },
                    {
                        "drugbank-id": "DB06787",
                        "description": "Mepyramine may increase the central nervous system depressant CNS depressant activities of Hexocyclium"
                    },
                    {
                        "drugbank-id": "DB08801",
                        "description": "Mepyramine may increase the central nervous system depressant CNS depressant activities of Dimetindene"
                    },
                    {
                        "drugbank-id": "DB08897",
                        "description": "Mepyramine may increase the central nervous system depressant CNS depressant activities of Aclidinium"
                    },
                    {
                        "drugbank-id": "DB08997",
                        "description": "Mepyramine may increase the central nervous system depressant CNS depressant activities of Dexetimide"
                    },
                    {
                        "drugbank-id": "DB09023",
                        "description": "Mepyramine may increase the central nervous system depressant CNS depressant activities of Benactyzine"
                    },
                    {
                        "drugbank-id": "DB09089",
                        "description": "Mepyramine may increase the central nervous system depressant CNS depressant activities of Trimebutine"
                    },
                    {
                        "drugbank-id": "DB09262",
                        "description": "Mepyramine may increase the central nervous system depressant CNS depressant activities of Imidafenacin"
                    },
                    {
                        "drugbank-id": "DB09300",
                        "description": "Mepyramine may increase the central nervous system depressant CNS depressant activities of Butylscopolamine"
                    },
                    {
                        "drugbank-id": "DB11235",
                        "description": "Mepyramine may increase the central nervous system depressant CNS depressant activities of Thonzylamine"
                    },
                    {
                        "drugbank-id": "DB11315",
                        "description": "Mepyramine may increase the central nervous system depressant CNS depressant activities of Methscopolamine"
                    },
                    {
                        "drugbank-id": "DB12086",
                        "description": "Mepyramine may increase the central nervous system depressant CNS depressant activities of Oxitropium"
                    },
                    {
                        "drugbank-id": "DB12278",
                        "description": "Mepyramine may increase the central nervous system depressant CNS depressant activities of Propiverine"
                    },
                    {
                        "drugbank-id": "DB12526",
                        "description": "Mepyramine may increase the central nervous system depressant CNS depressant activities of Batefenterol"
                    },
                    {
                        "drugbank-id": "DB12554",
                        "description": "Mepyramine may increase the central nervous system depressant CNS depressant activities of Mebeverine"
                    },
                    {
                        "drugbank-id": "DB13252",
                        "description": "Mepyramine may increase the central nervous system depressant CNS depressant activities of Tropatepine"
                    },
                    {
                        "drugbank-id": "DB13254",
                        "description": "Mepyramine may increase the central nervous system depressant CNS depressant activities of Prifinium"
                    },
                    {
                        "drugbank-id": "DB13351",
                        "description": "Mepyramine may increase the central nervous system depressant CNS depressant activities of Piperidolate"
                    },
                    {
                        "drugbank-id": "DB13369",
                        "description": "Mepyramine may increase the central nervous system depressant CNS depressant activities of Benzilone"
                    },
                    {
                        "drugbank-id": "DB13380",
                        "description": "Mepyramine may increase the central nervous system depressant CNS depressant activities of Difemerine"
                    },
                    {
                        "drugbank-id": "DB13413",
                        "description": "Mepyramine may increase the central nervous system depressant CNS depressant activities of Phenglutarimide"
                    },
                    {
                        "drugbank-id": "DB13448",
                        "description": "Mepyramine may increase the central nervous system depressant CNS depressant activities of Mazaticol"
                    },
                    {
                        "drugbank-id": "DB13468",
                        "description": "Mepyramine may increase the central nervous system depressant CNS depressant activities of Etybenzatropine"
                    },
                    {
                        "drugbank-id": "DB13505",
                        "description": "Mepyramine may increase the central nervous system depressant CNS depressant activities of Emepronium"
                    },
                    {
                        "drugbank-id": "DB13507",
                        "description": "Mepyramine may increase the central nervous system depressant CNS depressant activities of Poldine"
                    },
                    {
                        "drugbank-id": "DB13542",
                        "description": "Mepyramine may increase the central nervous system depressant CNS depressant activities of Bevonium"
                    },
                    {
                        "drugbank-id": "DB13581",
                        "description": "Mepyramine may increase the central nervous system depressant CNS depressant activities of Rociverine"
                    },
                    {
                        "drugbank-id": "DB13619",
                        "description": "Mepyramine may increase the central nervous system depressant CNS depressant activities of Bornaprine"
                    },
                    {
                        "drugbank-id": "DB13636",
                        "description": "Mepyramine may increase the central nervous system depressant CNS depressant activities of Etanautine"
                    },
                    {
                        "drugbank-id": "DB13666",
                        "description": "Mepyramine may increase the central nervous system depressant CNS depressant activities of Tiemonium iodide"
                    },
                    {
                        "drugbank-id": "DB13678",
                        "description": "Mepyramine may increase the central nervous system depressant CNS depressant activities of Dihexyverine"
                    },
                    {
                        "drugbank-id": "DB13695",
                        "description": "Mepyramine may increase the central nervous system depressant CNS depressant activities of Penthienate"
                    },
                    {
                        "drugbank-id": "DB13720",
                        "description": "Mepyramine may increase the central nervous system depressant CNS depressant activities of Diphemanil"
                    },
                    {
                        "drugbank-id": "DB13738",
                        "description": "Mepyramine may increase the central nervous system depressant CNS depressant activities of Camylofin"
                    },
                    {
                        "drugbank-id": "DB13759",
                        "description": "Mepyramine may increase the central nervous system depressant CNS depressant activities of Fenpiverinium"
                    },
                    {
                        "drugbank-id": "DB13769",
                        "description": "Mepyramine may increase the central nervous system depressant CNS depressant activities of Emetonium iodide"
                    },
                    {
                        "drugbank-id": "DB13844",
                        "description": "Mepyramine may increase the central nervous system depressant CNS depressant activities of Pipenzolate"
                    },
                    {
                        "drugbank-id": "DB13850",
                        "description": "Mepyramine may increase the central nervous system depressant CNS depressant activities of Timepidium"
                    },
                    {
                        "drugbank-id": "DB01142",
                        "description": "Mepyramine may increase the central nervous system depressant CNS depressant activities of Doxepin"
                    },
                    {
                        "drugbank-id": "DB09007",
                        "description": "Mepyramine may increase the central nervous system depressant CNS depressant activities of Chlorphenoxamine"
                    },
                    {
                        "drugbank-id": "DB01198",
                        "description": "The risk or severity of adverse effects can be increased when Mepyramine is combined with Zopiclone"
                    },
                    {
                        "drugbank-id": "DB00007",
                        "description": "The risk or severity of QTc prolongation can be increased when Mepyramine is combined with Leuprolide"
                    },
                    {
                        "drugbank-id": "DB00014",
                        "description": "The risk or severity of QTc prolongation can be increased when Mepyramine is combined with Goserelin"
                    },
                    {
                        "drugbank-id": "DB00199",
                        "description": "The risk or severity of QTc prolongation can be increased when Mepyramine is combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB00207",
                        "description": "The risk or severity of QTc prolongation can be increased when Mepyramine is combined with Azithromycin"
                    },
                    {
                        "drugbank-id": "DB00218",
                        "description": "The risk or severity of QTc prolongation can be increased when Mepyramine is combined with Moxifloxacin"
                    },
                    {
                        "drugbank-id": "DB00263",
                        "description": "The risk or severity of QTc prolongation can be increased when Mepyramine is combined with Sulfisoxazole"
                    },
                    {
                        "drugbank-id": "DB00391",
                        "description": "The risk or severity of QTc prolongation can be increased when Mepyramine is combined with Sulpiride"
                    },
                    {
                        "drugbank-id": "DB00393",
                        "description": "The risk or severity of QTc prolongation can be increased when Mepyramine is combined with Nimodipine"
                    },
                    {
                        "drugbank-id": "DB00526",
                        "description": "The risk or severity of QTc prolongation can be increased when Mepyramine is combined with Oxaliplatin"
                    },
                    {
                        "drugbank-id": "DB00537",
                        "description": "The risk or severity of QTc prolongation can be increased when Mepyramine is combined with Ciprofloxacin"
                    },
                    {
                        "drugbank-id": "DB00544",
                        "description": "The risk or severity of QTc prolongation can be increased when Mepyramine is combined with Fluorouracil"
                    },
                    {
                        "drugbank-id": "DB00556",
                        "description": "The risk or severity of QTc prolongation can be increased when Mepyramine is combined with Perflutren"
                    },
                    {
                        "drugbank-id": "DB00572",
                        "description": "The risk or severity of QTc prolongation can be increased when Mepyramine is combined with Atropine"
                    },
                    {
                        "drugbank-id": "DB00625",
                        "description": "The risk or severity of QTc prolongation can be increased when Mepyramine is combined with Efavirenz"
                    },
                    {
                        "drugbank-id": "DB00640",
                        "description": "The risk or severity of QTc prolongation can be increased when Mepyramine is combined with Adenosine"
                    },
                    {
                        "drugbank-id": "DB00743",
                        "description": "The risk or severity of QTc prolongation can be increased when Mepyramine is combined with Gadobenic acid"
                    },
                    {
                        "drugbank-id": "DB00748",
                        "description": "The risk or severity of QTc prolongation can be increased when Mepyramine is combined with Carbinoxamine"
                    },
                    {
                        "drugbank-id": "DB00778",
                        "description": "The risk or severity of QTc prolongation can be increased when Mepyramine is combined with Roxithromycin"
                    },
                    {
                        "drugbank-id": "DB00779",
                        "description": "The risk or severity of QTc prolongation can be increased when Mepyramine is combined with Nalidixic acid"
                    },
                    {
                        "drugbank-id": "DB00827",
                        "description": "The risk or severity of QTc prolongation can be increased when Mepyramine is combined with Cinoxacin"
                    },
                    {
                        "drugbank-id": "DB00889",
                        "description": "The risk or severity of QTc prolongation can be increased when Mepyramine is combined with Granisetron"
                    },
                    {
                        "drugbank-id": "DB00922",
                        "description": "The risk or severity of QTc prolongation can be increased when Mepyramine is combined with Levosimendan"
                    },
                    {
                        "drugbank-id": "DB00967",
                        "description": "The risk or severity of QTc prolongation can be increased when Mepyramine is combined with Desloratadine"
                    },
                    {
                        "drugbank-id": "DB00976",
                        "description": "The risk or severity of QTc prolongation can be increased when Mepyramine is combined with Telithromycin"
                    },
                    {
                        "drugbank-id": "DB00978",
                        "description": "The risk or severity of QTc prolongation can be increased when Mepyramine is combined with Lomefloxacin"
                    },
                    {
                        "drugbank-id": "DB00985",
                        "description": "The risk or severity of QTc prolongation can be increased when Mepyramine is combined with Dimenhydrinate"
                    },
                    {
                        "drugbank-id": "DB01087",
                        "description": "The risk or severity of QTc prolongation can be increased when Mepyramine is combined with Primaquine"
                    },
                    {
                        "drugbank-id": "DB01113",
                        "description": "The risk or severity of QTc prolongation can be increased when Mepyramine is combined with Papaverine"
                    },
                    {
                        "drugbank-id": "DB01137",
                        "description": "The risk or severity of QTc prolongation can be increased when Mepyramine is combined with Levofloxacin"
                    },
                    {
                        "drugbank-id": "DB01155",
                        "description": "The risk or severity of QTc prolongation can be increased when Mepyramine is combined with Gemifloxacin"
                    },
                    {
                        "drugbank-id": "DB01165",
                        "description": "The risk or severity of QTc prolongation can be increased when Mepyramine is combined with Ofloxacin"
                    },
                    {
                        "drugbank-id": "DB01211",
                        "description": "The risk or severity of QTc prolongation can be increased when Mepyramine is combined with Clarithromycin"
                    },
                    {
                        "drugbank-id": "DB01227",
                        "description": "The risk or severity of QTc prolongation can be increased when Mepyramine is combined with Levacetylmethadol"
                    },
                    {
                        "drugbank-id": "DB01232",
                        "description": "The risk or severity of QTc prolongation can be increased when Mepyramine is combined with Saquinavir"
                    },
                    {
                        "drugbank-id": "DB01388",
                        "description": "The risk or severity of QTc prolongation can be increased when Mepyramine is combined with Mibefradil"
                    },
                    {
                        "drugbank-id": "DB01599",
                        "description": "The risk or severity of QTc prolongation can be increased when Mepyramine is combined with Probucol"
                    },
                    {
                        "drugbank-id": "DB01615",
                        "description": "The risk or severity of QTc prolongation can be increased when Mepyramine is combined with Aceprometazine"
                    },
                    {
                        "drugbank-id": "DB02638",
                        "description": "The risk or severity of QTc prolongation can be increased when Mepyramine is combined with Terlipressin"
                    },
                    {
                        "drugbank-id": "DB04825",
                        "description": "The risk or severity of QTc prolongation can be increased when Mepyramine is combined with Prenylamine"
                    },
                    {
                        "drugbank-id": "DB04842",
                        "description": "The risk or severity of QTc prolongation can be increased when Mepyramine is combined with Fluspirilene"
                    },
                    {
                        "drugbank-id": "DB04957",
                        "description": "The risk or severity of QTc prolongation can be increased when Mepyramine is combined with Azimilide"
                    },
                    {
                        "drugbank-id": "DB05223",
                        "description": "The risk or severity of QTc prolongation can be increased when Mepyramine is combined with Pracinostat"
                    },
                    {
                        "drugbank-id": "DB05488",
                        "description": "The risk or severity of QTc prolongation can be increased when Mepyramine is combined with Technetium Tc 99m ciprofloxacin"
                    },
                    {
                        "drugbank-id": "DB06160",
                        "description": "The risk or severity of QTc prolongation can be increased when Mepyramine is combined with Garenoxacin"
                    },
                    {
                        "drugbank-id": "DB06200",
                        "description": "The risk or severity of QTc prolongation can be increased when Mepyramine is combined with Tedisamil"
                    },
                    {
                        "drugbank-id": "DB06334",
                        "description": "The risk or severity of QTc prolongation can be increased when Mepyramine is combined with Tucidinostat"
                    },
                    {
                        "drugbank-id": "DB06402",
                        "description": "The risk or severity of QTc prolongation can be increased when Mepyramine is combined with Telavancin"
                    },
                    {
                        "drugbank-id": "DB06600",
                        "description": "The risk or severity of QTc prolongation can be increased when Mepyramine is combined with Nemonoxacin"
                    },
                    {
                        "drugbank-id": "DB06603",
                        "description": "The risk or severity of QTc prolongation can be increased when Mepyramine is combined with Panobinostat"
                    },
                    {
                        "drugbank-id": "DB06712",
                        "description": "The risk or severity of QTc prolongation can be increased when Mepyramine is combined with Nilvadipine"
                    },
                    {
                        "drugbank-id": "DB08799",
                        "description": "The risk or severity of QTc prolongation can be increased when Mepyramine is combined with Antazoline"
                    },
                    {
                        "drugbank-id": "DB08865",
                        "description": "The risk or severity of QTc prolongation can be increased when Mepyramine is combined with Crizotinib"
                    },
                    {
                        "drugbank-id": "DB08903",
                        "description": "The risk or severity of QTc prolongation can be increased when Mepyramine is combined with Bedaquiline"
                    },
                    {
                        "drugbank-id": "DB08980",
                        "description": "The risk or severity of QTc prolongation can be increased when Mepyramine is combined with Fendiline"
                    },
                    {
                        "drugbank-id": "DB08992",
                        "description": "The risk or severity of QTc prolongation can be increased when Mepyramine is combined with Eperisone"
                    },
                    {
                        "drugbank-id": "DB09016",
                        "description": "The risk or severity of QTc prolongation can be increased when Mepyramine is combined with Butriptyline"
                    },
                    {
                        "drugbank-id": "DB09063",
                        "description": "The risk or severity of QTc prolongation can be increased when Mepyramine is combined with Ceritinib"
                    },
                    {
                        "drugbank-id": "DB09078",
                        "description": "The risk or severity of QTc prolongation can be increased when Mepyramine is combined with Lenvatinib"
                    },
                    {
                        "drugbank-id": "DB09224",
                        "description": "The risk or severity of QTc prolongation can be increased when Mepyramine is combined with Melperone"
                    },
                    {
                        "drugbank-id": "DB09231",
                        "description": "The risk or severity of QTc prolongation can be increased when Mepyramine is combined with Benidipine"
                    },
                    {
                        "drugbank-id": "DB11640",
                        "description": "The risk or severity of QTc prolongation can be increased when Mepyramine is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB11830",
                        "description": "The risk or severity of QTc prolongation can be increased when Mepyramine is combined with Mocetinostat"
                    },
                    {
                        "drugbank-id": "DB11841",
                        "description": "The risk or severity of QTc prolongation can be increased when Mepyramine is combined with Entinostat"
                    },
                    {
                        "drugbank-id": "DB12141",
                        "description": "The risk or severity of QTc prolongation can be increased when Mepyramine is combined with Gilteritinib"
                    },
                    {
                        "drugbank-id": "DB12174",
                        "description": "The risk or severity of QTc prolongation can be increased when Mepyramine is combined with CUDC 101"
                    },
                    {
                        "drugbank-id": "DB12286",
                        "description": "The risk or severity of QTc prolongation can be increased when Mepyramine is combined with Simendan"
                    },
                    {
                        "drugbank-id": "DB12376",
                        "description": "The risk or severity of QTc prolongation can be increased when Mepyramine is combined with Ricolinostat"
                    },
                    {
                        "drugbank-id": "DB12523",
                        "description": "The risk or severity of QTc prolongation can be increased when Mepyramine is combined with Mizolastine"
                    },
                    {
                        "drugbank-id": "DB12565",
                        "description": "The risk or severity of QTc prolongation can be increased when Mepyramine is combined with Abexinostat"
                    },
                    {
                        "drugbank-id": "DB12877",
                        "description": "The risk or severity of QTc prolongation can be increased when Mepyramine is combined with Oxatomide"
                    },
                    {
                        "drugbank-id": "DB13261",
                        "description": "The risk or severity of QTc prolongation can be increased when Mepyramine is combined with Sitafloxacin"
                    },
                    {
                        "drugbank-id": "DB13273",
                        "description": "The risk or severity of QTc prolongation can be increased when Mepyramine is combined with Sultopride"
                    },
                    {
                        "drugbank-id": "DB13500",
                        "description": "The risk or severity of QTc prolongation can be increased when Mepyramine is combined with Otilonium"
                    },
                    {
                        "drugbank-id": "DB13546",
                        "description": "The risk or severity of QTc prolongation can be increased when Mepyramine is combined with Nizofenone"
                    },
                    {
                        "drugbank-id": "DB13652",
                        "description": "The risk or severity of QTc prolongation can be increased when Mepyramine is combined with Bunaftine"
                    },
                    {
                        "drugbank-id": "DB13653",
                        "description": "The risk or severity of QTc prolongation can be increased when Mepyramine is combined with Lorcainide"
                    },
                    {
                        "drugbank-id": "DB13791",
                        "description": "The risk or severity of QTc prolongation can be increased when Mepyramine is combined with Penfluridol"
                    },
                    {
                        "drugbank-id": "DB14063",
                        "description": "The risk or severity of QTc prolongation can be increased when Mepyramine is combined with Dexverapamil"
                    },
                    {
                        "drugbank-id": "DB14568",
                        "description": "The risk or severity of QTc prolongation can be increased when Mepyramine is combined with Ivosidenib"
                    },
                    {
                        "drugbank-id": "DB01084",
                        "description": "The risk or severity of QTc prolongation can be increased when Mepyramine is combined with Emedastine"
                    },
                    {
                        "drugbank-id": "DB15982",
                        "description": "The risk or severity of QTc prolongation can be increased when Mepyramine is combined with Berotralstat"
                    },
                    {
                        "drugbank-id": "DB00204",
                        "description": "The risk or severity of QTc prolongation can be increased when Mepyramine is combined with Dofetilide"
                    },
                    {
                        "drugbank-id": "DB00261",
                        "description": "The risk or severity of QTc prolongation can be increased when Mepyramine is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB00280",
                        "description": "The risk or severity of QTc prolongation can be increased when Mepyramine is combined with Disopyramide"
                    },
                    {
                        "drugbank-id": "DB00283",
                        "description": "The risk or severity of QTc prolongation can be increased when Mepyramine is combined with Clemastine"
                    },
                    {
                        "drugbank-id": "DB00308",
                        "description": "The risk or severity of QTc prolongation can be increased when Mepyramine is combined with Ibutilide"
                    },
                    {
                        "drugbank-id": "DB00313",
                        "description": "The risk or severity of QTc prolongation can be increased when Mepyramine is combined with Valproic acid"
                    },
                    {
                        "drugbank-id": "DB00365",
                        "description": "The risk or severity of QTc prolongation can be increased when Mepyramine is combined with Grepafloxacin"
                    },
                    {
                        "drugbank-id": "DB00539",
                        "description": "The risk or severity of QTc prolongation can be increased when Mepyramine is combined with Toremifene"
                    },
                    {
                        "drugbank-id": "DB00604",
                        "description": "The risk or severity of QTc prolongation can be increased when Mepyramine is combined with Cisapride"
                    },
                    {
                        "drugbank-id": "DB00685",
                        "description": "The risk or severity of QTc prolongation can be increased when Mepyramine is combined with Trovafloxacin"
                    },
                    {
                        "drugbank-id": "DB00834",
                        "description": "The risk or severity of QTc prolongation can be increased when Mepyramine is combined with Mifepristone"
                    },
                    {
                        "drugbank-id": "DB00875",
                        "description": "The risk or severity of QTc prolongation can be increased when Mepyramine is combined with Flupentixol"
                    },
                    {
                        "drugbank-id": "DB00907",
                        "description": "The risk or severity of QTc prolongation can be increased when Mepyramine is combined with Cocaine"
                    },
                    {
                        "drugbank-id": "DB00908",
                        "description": "The risk or severity of QTc prolongation can be increased when Mepyramine is combined with Quinidine"
                    },
                    {
                        "drugbank-id": "DB01169",
                        "description": "The risk or severity of QTc prolongation can be increased when Mepyramine is combined with Arsenic trioxide"
                    },
                    {
                        "drugbank-id": "DB01208",
                        "description": "The risk or severity of QTc prolongation can be increased when Mepyramine is combined with Sparfloxacin"
                    },
                    {
                        "drugbank-id": "DB01218",
                        "description": "The risk or severity of QTc prolongation can be increased when Mepyramine is combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB01356",
                        "description": "The risk or severity of QTc prolongation can be increased when Mepyramine is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB01405",
                        "description": "The risk or severity of QTc prolongation can be increased when Mepyramine is combined with Temafloxacin"
                    },
                    {
                        "drugbank-id": "DB04868",
                        "description": "The risk or severity of QTc prolongation can be increased when Mepyramine is combined with Nilotinib"
                    },
                    {
                        "drugbank-id": "DB05294",
                        "description": "The risk or severity of QTc prolongation can be increased when Mepyramine is combined with Vandetanib"
                    },
                    {
                        "drugbank-id": "DB06176",
                        "description": "The risk or severity of QTc prolongation can be increased when Mepyramine is combined with Romidepsin"
                    },
                    {
                        "drugbank-id": "DB06216",
                        "description": "The risk or severity of QTc prolongation can be increased when Mepyramine is combined with Asenapine"
                    },
                    {
                        "drugbank-id": "DB06708",
                        "description": "The risk or severity of QTc prolongation can be increased when Mepyramine is combined with Lumefantrine"
                    },
                    {
                        "drugbank-id": "DB09083",
                        "description": "The risk or severity of QTc prolongation can be increased when Mepyramine is combined with Ivabradine"
                    },
                    {
                        "drugbank-id": "DB11730",
                        "description": "The risk or severity of QTc prolongation can be increased when Mepyramine is combined with Ribociclib"
                    },
                    {
                        "drugbank-id": "DB11978",
                        "description": "The risk or severity of QTc prolongation can be increased when Mepyramine is combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB13074",
                        "description": "The risk or severity of QTc prolongation can be increased when Mepyramine is combined with Macimorelin"
                    },
                    {
                        "drugbank-id": "DB13725",
                        "description": "The risk or severity of QTc prolongation can be increased when Mepyramine is combined with Terodiline"
                    },
                    {
                        "drugbank-id": "DB00342",
                        "description": "The risk or severity of QTc prolongation can be increased when Mepyramine is combined with Terfenadine"
                    },
                    {
                        "drugbank-id": "DB00468",
                        "description": "The risk or severity of QTc prolongation can be increased when Quinine is combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB00679",
                        "description": "The risk or severity of QTc prolongation can be increased when Thioridazine is combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB01267",
                        "description": "The risk or severity of QTc prolongation can be increased when Paliperidone is combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB01624",
                        "description": "The risk or severity of QTc prolongation can be increased when Zuclopenthixol is combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB04946",
                        "description": "The risk or severity of QTc prolongation can be increased when Iloperidone is combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB00619",
                        "description": "The risk or severity of QTc prolongation can be increased when Mepyramine is combined with Imatinib"
                    },
                    {
                        "drugbank-id": "DB01184",
                        "description": "The risk or severity of QTc prolongation can be increased when Mepyramine is combined with Domperidone"
                    },
                    {
                        "drugbank-id": "DB01244",
                        "description": "The risk or severity of QTc prolongation can be increased when Mepyramine is combined with Bepridil"
                    },
                    {
                        "drugbank-id": "DB04855",
                        "description": "The risk or severity of QTc prolongation can be increased when Mepyramine is combined with Dronedarone"
                    },
                    {
                        "drugbank-id": "DB09039",
                        "description": "The risk or severity of QTc prolongation can be increased when Mepyramine is combined with Eliglustat"
                    },
                    {
                        "drugbank-id": "DB06697",
                        "description": "The risk or severity of QTc prolongation can be increased when Mepyramine is combined with Artemether"
                    },
                    {
                        "drugbank-id": "DB01118",
                        "description": "The risk or severity of QTc prolongation can be increased when Mepyramine is combined with Amiodarone"
                    },
                    {
                        "drugbank-id": "DB00042",
                        "description": "The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB00083",
                        "description": "The risk or severity of adverse effects can be increased when Botulinum toxin type A is combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB00150",
                        "description": "The risk or severity of adverse effects can be increased when Tryptophan is combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB00181",
                        "description": "The risk or severity of adverse effects can be increased when Baclofen is combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB00186",
                        "description": "The risk or severity of adverse effects can be increased when Lorazepam is combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB00189",
                        "description": "The risk or severity of adverse effects can be increased when Ethchlorvynol is combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB00202",
                        "description": "The risk or severity of adverse effects can be increased when Succinylcholine is combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB00206",
                        "description": "The risk or severity of adverse effects can be increased when Reserpine is combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB00228",
                        "description": "The risk or severity of adverse effects can be increased when Enflurane is combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB00231",
                        "description": "The risk or severity of adverse effects can be increased when Temazepam is combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB00234",
                        "description": "The risk or severity of adverse effects can be increased when Reboxetine is combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB00237",
                        "description": "The risk or severity of adverse effects can be increased when Butabarbital is combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB00241",
                        "description": "The risk or severity of adverse effects can be increased when Butalbital is combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB00247",
                        "description": "The risk or severity of adverse effects can be increased when Methysergide is combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB00248",
                        "description": "The risk or severity of adverse effects can be increased when Cabergoline is combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB00252",
                        "description": "The risk or severity of adverse effects can be increased when Phenytoin is combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB00273",
                        "description": "The risk or severity of adverse effects can be increased when Topiramate is combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB00292",
                        "description": "The risk or severity of adverse effects can be increased when Etomidate is combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB00306",
                        "description": "The risk or severity of adverse effects can be increased when Talbutal is combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB00312",
                        "description": "The risk or severity of adverse effects can be increased when Pentobarbital is combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB00315",
                        "description": "The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB00320",
                        "description": "The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB00323",
                        "description": "The risk or severity of adverse effects can be increased when Tolcapone is combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB00327",
                        "description": "The risk or severity of adverse effects can be increased when Hydromorphone is combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB00341",
                        "description": "The risk or severity of adverse effects can be increased when Cetirizine is combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB00347",
                        "description": "The risk or severity of adverse effects can be increased when Trimethadione is combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB00349",
                        "description": "The risk or severity of adverse effects can be increased when Clobazam is combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB00371",
                        "description": "The risk or severity of adverse effects can be increased when Meprobamate is combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB00372",
                        "description": "The risk or severity of adverse effects can be increased when Thiethylperazine is combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB00404",
                        "description": "The risk or severity of adverse effects can be increased when Alprazolam is combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB00405",
                        "description": "The risk or severity of adverse effects can be increased when Dexbrompheniramine is combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB00408",
                        "description": "The risk or severity of adverse effects can be increased when Loxapine is combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB00416",
                        "description": "The risk or severity of adverse effects can be increased when Metocurine iodide is combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB00418",
                        "description": "The risk or severity of adverse effects can be increased when Secobarbital is combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB00423",
                        "description": "The risk or severity of adverse effects can be increased when Methocarbamol is combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB00427",
                        "description": "The risk or severity of adverse effects can be increased when Triprolidine is combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB00463",
                        "description": "The risk or severity of adverse effects can be increased when Metharbital is combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB00474",
                        "description": "The risk or severity of adverse effects can be increased when Methohexital is combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB00475",
                        "description": "The risk or severity of adverse effects can be increased when Chlordiazepoxide is combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB00494",
                        "description": "The risk or severity of adverse effects can be increased when Entacapone is combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB00546",
                        "description": "The risk or severity of adverse effects can be increased when Adinazolam is combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB00564",
                        "description": "The risk or severity of adverse effects can be increased when Carbamazepine is combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB00565",
                        "description": "The risk or severity of adverse effects can be increased when Cisatracurium is combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB00574",
                        "description": "The risk or severity of adverse effects can be increased when Fenfluramine is combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB00579",
                        "description": "The risk or severity of adverse effects can be increased when Mazindol is combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB00588",
                        "description": "The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB00593",
                        "description": "The risk or severity of adverse effects can be increased when Ethosuximide is combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB00599",
                        "description": "The risk or severity of adverse effects can be increased when Thiopental is combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB00601",
                        "description": "The risk or severity of adverse effects can be increased when Linezolid is combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB00611",
                        "description": "The risk or severity of adverse effects can be increased when Butorphanol is combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB00614",
                        "description": "The risk or severity of adverse effects can be increased when Furazolidone is combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB00617",
                        "description": "The risk or severity of adverse effects can be increased when Paramethadione is combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB00623",
                        "description": "The risk or severity of adverse effects can be increased when Fluphenazine is combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB00628",
                        "description": "The risk or severity of adverse effects can be increased when Clorazepic acid is combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB00633",
                        "description": "The risk or severity of adverse effects can be increased when Dexmedetomidine is combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB00645",
                        "description": "The risk or severity of adverse effects can be increased when Dyclonine is combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB00652",
                        "description": "The risk or severity of adverse effects can be increased when Pentazocine is combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB00660",
                        "description": "The risk or severity of adverse effects can be increased when Metaxalone is combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB00662",
                        "description": "The risk or severity of adverse effects can be increased when Trimethobenzamide is combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB00669",
                        "description": "The risk or severity of adverse effects can be increased when Sumatriptan is combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB00680",
                        "description": "The risk or severity of adverse effects can be increased when Moricizine is combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB00683",
                        "description": "The risk or severity of adverse effects can be increased when Midazolam is combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB00690",
                        "description": "The risk or severity of adverse effects can be increased when Flurazepam is combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB00696",
                        "description": "The risk or severity of adverse effects can be increased when Ergotamine is combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB00697",
                        "description": "The risk or severity of adverse effects can be increased when Tizanidine is combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB00708",
                        "description": "The risk or severity of adverse effects can be increased when Sufentanil is combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB00714",
                        "description": "The risk or severity of adverse effects can be increased when Apomorphine is combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB00721",
                        "description": "The risk or severity of adverse effects can be increased when Procaine is combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB00732",
                        "description": "The risk or severity of adverse effects can be increased when Atracurium besylate is combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB00740",
                        "description": "The risk or severity of adverse effects can be increased when Riluzole is combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB00752",
                        "description": "The risk or severity of adverse effects can be increased when Tranylcypromine is combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB00753",
                        "description": "The risk or severity of adverse effects can be increased when Isoflurane is combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB00754",
                        "description": "The risk or severity of adverse effects can be increased when Ethotoin is combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB00776",
                        "description": "The risk or severity of adverse effects can be increased when Oxcarbazepine is combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB00780",
                        "description": "The risk or severity of adverse effects can be increased when Phenelzine is combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB00794",
                        "description": "The risk or severity of adverse effects can be increased when Primidone is combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB00801",
                        "description": "The risk or severity of adverse effects can be increased when Halazepam is combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB00802",
                        "description": "The risk or severity of adverse effects can be increased when Alfentanil is combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB00813",
                        "description": "The risk or severity of adverse effects can be increased when Fentanyl is combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB00818",
                        "description": "The risk or severity of adverse effects can be increased when Propofol is combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB00819",
                        "description": "The risk or severity of adverse effects can be increased when Acetazolamide is combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB00829",
                        "description": "The risk or severity of adverse effects can be increased when Diazepam is combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB00831",
                        "description": "The risk or severity of adverse effects can be increased when Trifluoperazine is combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB00832",
                        "description": "The risk or severity of adverse effects can be increased when Phensuximide is combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB00837",
                        "description": "The risk or severity of adverse effects can be increased when Progabide is combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB00842",
                        "description": "The risk or severity of adverse effects can be increased when Oxazepam is combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB00844",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB00849",
                        "description": "The risk or severity of adverse effects can be increased when Methylphenobarbital is combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB00854",
                        "description": "The risk or severity of adverse effects can be increased when Levorphanol is combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB00897",
                        "description": "The risk or severity of adverse effects can be increased when Triazolam is combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB00899",
                        "description": "The risk or severity of adverse effects can be increased when Remifentanil is combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB00906",
                        "description": "The risk or severity of adverse effects can be increased when Tiagabine is combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB00909",
                        "description": "The risk or severity of adverse effects can be increased when Zonisamide is combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB00941",
                        "description": "The risk or severity of adverse effects can be increased when Hexafluronium is combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB00949",
                        "description": "The risk or severity of adverse effects can be increased when Felbamate is combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB00952",
                        "description": "The risk or severity of adverse effects can be increased when Naratriptan is combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB00953",
                        "description": "The risk or severity of adverse effects can be increased when Rizatriptan is combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB00962",
                        "description": "The risk or severity of adverse effects can be increased when Zaleplon is combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB00969",
                        "description": "The risk or severity of adverse effects can be increased when Alosetron is combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB00980",
                        "description": "The risk or severity of adverse effects can be increased when Ramelteon is combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB00996",
                        "description": "The risk or severity of adverse effects can be increased when Gabapentin is combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB00998",
                        "description": "The risk or severity of adverse effects can be increased when Frovatriptan is combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB01018",
                        "description": "The risk or severity of adverse effects can be increased when Guanfacine is combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB01049",
                        "description": "The risk or severity of adverse effects can be increased when Ergoloid mesylate is combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB01063",
                        "description": "The risk or severity of adverse effects can be increased when Acetophenazine is combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB01065",
                        "description": "The risk or severity of adverse effects can be increased when Melatonin is combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB01068",
                        "description": "The risk or severity of adverse effects can be increased when Clonazepam is combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB01080",
                        "description": "The risk or severity of adverse effects can be increased when Vigabatrin is combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB01081",
                        "description": "The risk or severity of adverse effects can be increased when Diphenoxylate is combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB01107",
                        "description": "The risk or severity of adverse effects can be increased when Methyprylon is combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB01121",
                        "description": "The risk or severity of adverse effects can be increased when Phenacemide is combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB01154",
                        "description": "The risk or severity of adverse effects can be increased when Thiamylal is combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB01159",
                        "description": "The risk or severity of adverse effects can be increased when Halothane is combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB01168",
                        "description": "The risk or severity of adverse effects can be increased when Procarbazine is combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB01174",
                        "description": "The risk or severity of adverse effects can be increased when Phenobarbital is combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB01176",
                        "description": "The risk or severity of adverse effects can be increased when Cyclizine is combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB01178",
                        "description": "The risk or severity of adverse effects can be increased when Chlormezanone is combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB01186",
                        "description": "The risk or severity of adverse effects can be increased when Pergolide is combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB01189",
                        "description": "The risk or severity of adverse effects can be increased when Desflurane is combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB01199",
                        "description": "The risk or severity of adverse effects can be increased when Tubocurarine is combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB01200",
                        "description": "The risk or severity of adverse effects can be increased when Bromocriptine is combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB01202",
                        "description": "The risk or severity of adverse effects can be increased when Levetiracetam is combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB01209",
                        "description": "The risk or severity of adverse effects can be increased when Dezocine is combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB01215",
                        "description": "The risk or severity of adverse effects can be increased when Estazolam is combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB01219",
                        "description": "The risk or severity of adverse effects can be increased when Dantrolene is combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB01221",
                        "description": "The risk or severity of adverse effects can be increased when Ketamine is combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB01235",
                        "description": "The risk or severity of adverse effects can be increased when Levodopa is combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB01236",
                        "description": "The risk or severity of adverse effects can be increased when Sevoflurane is combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB01245",
                        "description": "The risk or severity of adverse effects can be increased when Decamethonium is combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB01246",
                        "description": "The risk or severity of adverse effects can be increased when Alimemazine is combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB01247",
                        "description": "The risk or severity of adverse effects can be increased when Isocarboxazid is combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB01253",
                        "description": "The risk or severity of adverse effects can be increased when Ergometrine is combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB01320",
                        "description": "The risk or severity of adverse effects can be increased when Fosphenytoin is combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB01323",
                        "description": "The risk or severity of adverse effects can be increased when St John s Wort is combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB01339",
                        "description": "The risk or severity of adverse effects can be increased when Vecuronium is combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB01351",
                        "description": "The risk or severity of adverse effects can be increased when Amobarbital is combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB01352",
                        "description": "The risk or severity of adverse effects can be increased when Aprobarbital is combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB01353",
                        "description": "The risk or severity of adverse effects can be increased when Butobarbital is combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB01354",
                        "description": "The risk or severity of adverse effects can be increased when Heptabarbital is combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB01355",
                        "description": "The risk or severity of adverse effects can be increased when Hexobarbital is combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB01367",
                        "description": "The risk or severity of adverse effects can be increased when Rasagiline is combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB01433",
                        "description": "The risk or severity of adverse effects can be increased when Methadyl acetate is combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB01437",
                        "description": "The risk or severity of adverse effects can be increased when Glutethimide is combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB01440",
                        "description": "The risk or severity of adverse effects can be increased when gamma Hydroxybutyric acid is combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB01445",
                        "description": "The risk or severity of adverse effects can be increased when Bufotenine is combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB01450",
                        "description": "The risk or severity of adverse effects can be increased when Dihydroetorphine is combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB01452",
                        "description": "The risk or severity of adverse effects can be increased when Diamorphine is combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB01463",
                        "description": "The risk or severity of adverse effects can be increased when Fencamfamin is combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB01483",
                        "description": "The risk or severity of adverse effects can be increased when Barbital is combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB01488",
                        "description": "The risk or severity of adverse effects can be increased when Dimethyltryptamine is combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB01489",
                        "description": "The risk or severity of adverse effects can be increased when Camazepam is combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB01495",
                        "description": "The risk or severity of adverse effects can be increased when Dichloralphenazone is combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB01497",
                        "description": "The risk or severity of adverse effects can be increased when Etorphine is combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB01501",
                        "description": "The risk or severity of adverse effects can be increased when Difenoxin is combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB01511",
                        "description": "The risk or severity of adverse effects can be increased when Delorazepam is combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB01529",
                        "description": "The risk or severity of adverse effects can be increased when Dextromoramide is combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB01531",
                        "description": "The risk or severity of adverse effects can be increased when Desomorphine is combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB01534",
                        "description": "The risk or severity of adverse effects can be increased when Chlorhexadol is combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB01535",
                        "description": "The risk or severity of adverse effects can be increased when Carfentanil is combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB01544",
                        "description": "The risk or severity of adverse effects can be increased when Flunitrazepam is combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB01545",
                        "description": "The risk or severity of adverse effects can be increased when Ethyl loflazepate is combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB01547",
                        "description": "The risk or severity of adverse effects can be increased when Drotebanol is combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB01553",
                        "description": "The risk or severity of adverse effects can be increased when Cloxazolam is combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB01555",
                        "description": "The risk or severity of adverse effects can be increased when Alphacetylmethadol is combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB01558",
                        "description": "The risk or severity of adverse effects can be increased when Bromazepam is combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB01559",
                        "description": "The risk or severity of adverse effects can be increased when Clotiazepam is combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB01560",
                        "description": "The risk or severity of adverse effects can be increased when Cathinone is combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB01563",
                        "description": "The risk or severity of adverse effects can be increased when Chloral hydrate is combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB01565",
                        "description": "The risk or severity of adverse effects can be increased when Dihydromorphine is combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB01567",
                        "description": "The risk or severity of adverse effects can be increased when Fludiazepam is combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB01587",
                        "description": "The risk or severity of adverse effects can be increased when Ketazolam is combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB01588",
                        "description": "The risk or severity of adverse effects can be increased when Prazepam is combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB01589",
                        "description": "The risk or severity of adverse effects can be increased when Quazepam is combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB01594",
                        "description": "The risk or severity of adverse effects can be increased when Cinolazepam is combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB01595",
                        "description": "The risk or severity of adverse effects can be increased when Nitrazepam is combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB01608",
                        "description": "The risk or severity of adverse effects can be increased when Periciazine is combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB01614",
                        "description": "The risk or severity of adverse effects can be increased when Acepromazine is combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB01616",
                        "description": "The risk or severity of adverse effects can be increased when Alverine is combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB01618",
                        "description": "The risk or severity of adverse effects can be increased when Molindone is combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB01622",
                        "description": "The risk or severity of adverse effects can be increased when Thioproperazine is combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB01623",
                        "description": "The risk or severity of adverse effects can be increased when Thiothixene is combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB01626",
                        "description": "The risk or severity of adverse effects can be increased when Pargyline is combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB01954",
                        "description": "The risk or severity of adverse effects can be increased when Rolipram is combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB02207",
                        "description": "The risk or severity of adverse effects can be increased when 7 Nitroindazole is combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB02234",
                        "description": "The risk or severity of adverse effects can be increased when S Ethylisothiourea is combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB02852",
                        "description": "The risk or severity of adverse effects can be increased when Domoic Acid is combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB02959",
                        "description": "The risk or severity of adverse effects can be increased when Oxitriptan is combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB03575",
                        "description": "The risk or severity of adverse effects can be increased when Phencyclidine is combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB04017",
                        "description": "The risk or severity of adverse effects can be increased when Clorgiline is combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB04165",
                        "description": "The risk or severity of adverse effects can be increased when Valpromide is combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB04325",
                        "description": "The risk or severity of adverse effects can be increased when Phenethylamine is combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB04599",
                        "description": "The risk or severity of adverse effects can be increased when Aniracetam is combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB04818",
                        "description": "The risk or severity of adverse effects can be increased when Iproniazid is combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB04819",
                        "description": "The risk or severity of adverse effects can be increased when Methapyrilene is combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB04820",
                        "description": "The risk or severity of adverse effects can be increased when Nialamide is combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB04821",
                        "description": "The risk or severity of adverse effects can be increased when Nomifensine is combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB04827",
                        "description": "The risk or severity of adverse effects can be increased when Urethane is combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB04833",
                        "description": "The risk or severity of adverse effects can be increased when Methaqualone is combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB04836",
                        "description": "The risk or severity of adverse effects can be increased when Amineptine is combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB04872",
                        "description": "The risk or severity of adverse effects can be increased when Osanetant is combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB04885",
                        "description": "The risk or severity of adverse effects can be increased when Cilansetron is combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB04888",
                        "description": "The risk or severity of adverse effects can be increased when Bifeprunox is combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB04903",
                        "description": "The risk or severity of adverse effects can be increased when Pagoclone is combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB04908",
                        "description": "The risk or severity of adverse effects can be increased when Flibanserin is combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB04917",
                        "description": "The risk or severity of adverse effects can be increased when Renzapride is combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB04953",
                        "description": "The risk or severity of adverse effects can be increased when Ezogabine is combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB05227",
                        "description": "The risk or severity of adverse effects can be increased when APD791 is combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB05232",
                        "description": "The risk or severity of adverse effects can be increased when Tetrodotoxin is combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB05246",
                        "description": "The risk or severity of adverse effects can be increased when Methsuximide is combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB05316",
                        "description": "The risk or severity of adverse effects can be increased when Pimavanserin is combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB05541",
                        "description": "The risk or severity of adverse effects can be increased when Brivaracetam is combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB05542",
                        "description": "The risk or severity of adverse effects can be increased when Naronapride is combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB05562",
                        "description": "The risk or severity of adverse effects can be increased when Naluzotan is combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB05607",
                        "description": "The risk or severity of adverse effects can be increased when PRX 08066 is combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB05687",
                        "description": "The risk or severity of adverse effects can be increased when BL 1020 is combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB05710",
                        "description": "The risk or severity of adverse effects can be increased when Gantacurium is combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB06077",
                        "description": "The risk or severity of adverse effects can be increased when Lumateperone is combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB06109",
                        "description": "The risk or severity of adverse effects can be increased when YKP 1358 is combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB06218",
                        "description": "The risk or severity of adverse effects can be increased when Lacosamide is combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB06264",
                        "description": "The risk or severity of adverse effects can be increased when Tolperisone is combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB06282",
                        "description": "The risk or severity of adverse effects can be increased when Levocetirizine is combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB06288",
                        "description": "The risk or severity of adverse effects can be increased when Amisulpride is combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB06446",
                        "description": "The risk or severity of adverse effects can be increased when Dotarizine is combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB06458",
                        "description": "The risk or severity of adverse effects can be increased when Remacemide is combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB06470",
                        "description": "The risk or severity of adverse effects can be increased when Clomethiazole is combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB06512",
                        "description": "The risk or severity of adverse effects can be increased when Deramciclane is combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB06527",
                        "description": "The risk or severity of adverse effects can be increased when Tramiprosate is combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB06529",
                        "description": "The risk or severity of adverse effects can be increased when Ocinaplon is combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB06554",
                        "description": "The risk or severity of adverse effects can be increased when Gaboxadol is combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB06579",
                        "description": "The risk or severity of adverse effects can be increased when Adipiplon is combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB06582",
                        "description": "The risk or severity of adverse effects can be increased when Dextofisopam is combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB06594",
                        "description": "The risk or severity of adverse effects can be increased when Agomelatine is combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB06654",
                        "description": "The risk or severity of adverse effects can be increased when Safinamide is combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB06660",
                        "description": "The risk or severity of adverse effects can be increased when Saredutant is combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB06690",
                        "description": "The risk or severity of adverse effects can be increased when Nitrous oxide is combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB06701",
                        "description": "The risk or severity of adverse effects can be increased when Mepyramine is combined with Dexmethylphenidate"
                    },
                    {
                        "drugbank-id": "DB06716",
                        "description": "The risk or severity of adverse effects can be increased when Mepyramine is combined with Fospropofol"
                    },
                    {
                        "drugbank-id": "DB06738",
                        "description": "The risk or severity of adverse effects can be increased when Mepyramine is combined with Ketobemidone"
                    },
                    {
                        "drugbank-id": "DB06753",
                        "description": "The risk or severity of adverse effects can be increased when Mepyramine is combined with Triclofos"
                    },
                    {
                        "drugbank-id": "DB06797",
                        "description": "The risk or severity of adverse effects can be increased when Mepyramine is combined with Mebutamate"
                    },
                    {
                        "drugbank-id": "DB08059",
                        "description": "The risk or severity of adverse effects can be increased when Mepyramine is combined with Wortmannin"
                    },
                    {
                        "drugbank-id": "DB08329",
                        "description": "The risk or severity of adverse effects can be increased when Mepyramine is combined with Sulthiame"
                    },
                    {
                        "drugbank-id": "DB08550",
                        "description": "The risk or severity of adverse effects can be increased when Mepyramine is combined with 7 8 Dichloro 1 2 3 4 tetrahydroisoquinoline"
                    },
                    {
                        "drugbank-id": "DB08810",
                        "description": "The risk or severity of adverse effects can be increased when Mepyramine is combined with Cinitapride"
                    },
                    {
                        "drugbank-id": "DB08811",
                        "description": "The risk or severity of adverse effects can be increased when Mepyramine is combined with Tofisopam"
                    },
                    {
                        "drugbank-id": "DB08815",
                        "description": "The risk or severity of adverse effects can be increased when Mepyramine is combined with Lurasidone"
                    },
                    {
                        "drugbank-id": "DB08839",
                        "description": "The risk or severity of adverse effects can be increased when Mepyramine is combined with Serotonin"
                    },
                    {
                        "drugbank-id": "DB08861",
                        "description": "The risk or severity of adverse effects can be increased when Mepyramine is combined with DPDPE"
                    },
                    {
                        "drugbank-id": "DB08872",
                        "description": "The risk or severity of adverse effects can be increased when Mepyramine is combined with Gabapentin enacarbil"
                    },
                    {
                        "drugbank-id": "DB08892",
                        "description": "The risk or severity of adverse effects can be increased when Mepyramine is combined with Arbaclofen Placarbil"
                    },
                    {
                        "drugbank-id": "DB08910",
                        "description": "The risk or severity of adverse effects can be increased when Mepyramine is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB08927",
                        "description": "The risk or severity of adverse effects can be increased when Mepyramine is combined with Amperozide"
                    },
                    {
                        "drugbank-id": "DB08954",
                        "description": "The risk or severity of adverse effects can be increased when Mepyramine is combined with Ifenprodil"
                    },
                    {
                        "drugbank-id": "DB08960",
                        "description": "The risk or severity of adverse effects can be increased when Mepyramine is combined with Hexamethonium"
                    },
                    {
                        "drugbank-id": "DB08986",
                        "description": "The risk or severity of adverse effects can be increased when Mepyramine is combined with Etifoxine"
                    },
                    {
                        "drugbank-id": "DB08996",
                        "description": "The risk or severity of adverse effects can be increased when Mepyramine is combined with Dimetacrine"
                    },
                    {
                        "drugbank-id": "DB09000",
                        "description": "The risk or severity of adverse effects can be increased when Mepyramine is combined with Cyamemazine"
                    },
                    {
                        "drugbank-id": "DB09001",
                        "description": "The risk or severity of adverse effects can be increased when Mepyramine is combined with Barbexaclone"
                    },
                    {
                        "drugbank-id": "DB09011",
                        "description": "The risk or severity of adverse effects can be increased when Mepyramine is combined with Beclamide"
                    },
                    {
                        "drugbank-id": "DB09014",
                        "description": "The risk or severity of adverse effects can be increased when Mepyramine is combined with Captodiame"
                    },
                    {
                        "drugbank-id": "DB09017",
                        "description": "The risk or severity of adverse effects can be increased when Mepyramine is combined with Brotizolam"
                    },
                    {
                        "drugbank-id": "DB09021",
                        "description": "The risk or severity of adverse effects can be increased when Mepyramine is combined with Benzoctamine"
                    },
                    {
                        "drugbank-id": "DB09071",
                        "description": "The risk or severity of adverse effects can be increased when Mepyramine is combined with Tasimelteon"
                    },
                    {
                        "drugbank-id": "DB09118",
                        "description": "The risk or severity of adverse effects can be increased when Mepyramine is combined with Stiripentol"
                    },
                    {
                        "drugbank-id": "DB09119",
                        "description": "The risk or severity of adverse effects can be increased when Mepyramine is combined with Eslicarbazepine acetate"
                    },
                    {
                        "drugbank-id": "DB09166",
                        "description": "The risk or severity of adverse effects can be increased when Mepyramine is combined with Etizolam"
                    },
                    {
                        "drugbank-id": "DB09174",
                        "description": "The risk or severity of adverse effects can be increased when Mepyramine is combined with Lofentanil"
                    },
                    {
                        "drugbank-id": "DB09184",
                        "description": "The risk or severity of adverse effects can be increased when Mepyramine is combined with Edivoxetine"
                    },
                    {
                        "drugbank-id": "DB09185",
                        "description": "The risk or severity of adverse effects can be increased when Mepyramine is combined with Viloxazine"
                    },
                    {
                        "drugbank-id": "DB09186",
                        "description": "The risk or severity of adverse effects can be increased when Mepyramine is combined with Nisoxetine"
                    },
                    {
                        "drugbank-id": "DB09187",
                        "description": "The risk or severity of adverse effects can be increased when Mepyramine is combined with Lortalamine"
                    },
                    {
                        "drugbank-id": "DB09190",
                        "description": "The risk or severity of adverse effects can be increased when Mepyramine is combined with Talopram"
                    },
                    {
                        "drugbank-id": "DB09194",
                        "description": "The risk or severity of adverse effects can be increased when Mepyramine is combined with Etoperidone"
                    },
                    {
                        "drugbank-id": "DB09223",
                        "description": "The risk or severity of adverse effects can be increased when Mepyramine is combined with Blonanserin"
                    },
                    {
                        "drugbank-id": "DB09225",
                        "description": "The risk or severity of adverse effects can be increased when Mepyramine is combined with Zotepine"
                    },
                    {
                        "drugbank-id": "DB09226",
                        "description": "The risk or severity of adverse effects can be increased when Mepyramine is combined with Brilaroxazine"
                    },
                    {
                        "drugbank-id": "DB09241",
                        "description": "The risk or severity of adverse effects can be increased when Mepyramine is combined with Methylene blue"
                    },
                    {
                        "drugbank-id": "DB09243",
                        "description": "The risk or severity of adverse effects can be increased when Mepyramine is combined with Hydracarbazine"
                    },
                    {
                        "drugbank-id": "DB09244",
                        "description": "The risk or severity of adverse effects can be increased when Mepyramine is combined with Pirlindole"
                    },
                    {
                        "drugbank-id": "DB09245",
                        "description": "The risk or severity of adverse effects can be increased when Mepyramine is combined with Toloxatone"
                    },
                    {
                        "drugbank-id": "DB09246",
                        "description": "The risk or severity of adverse effects can be increased when Mepyramine is combined with Benmoxin"
                    },
                    {
                        "drugbank-id": "DB09247",
                        "description": "The risk or severity of adverse effects can be increased when Mepyramine is combined with Iproclozide"
                    },
                    {
                        "drugbank-id": "DB09248",
                        "description": "The risk or severity of adverse effects can be increased when Mepyramine is combined with Mebanazine"
                    },
                    {
                        "drugbank-id": "DB09249",
                        "description": "The risk or severity of adverse effects can be increased when Mepyramine is combined with Octamoxin"
                    },
                    {
                        "drugbank-id": "DB09250",
                        "description": "The risk or severity of adverse effects can be increased when Mepyramine is combined with Pheniprazine"
                    },
                    {
                        "drugbank-id": "DB09251",
                        "description": "The risk or severity of adverse effects can be increased when Mepyramine is combined with Phenoxypropazine"
                    },
                    {
                        "drugbank-id": "DB09252",
                        "description": "The risk or severity of adverse effects can be increased when Mepyramine is combined with Pivhydrazine"
                    },
                    {
                        "drugbank-id": "DB09253",
                        "description": "The risk or severity of adverse effects can be increased when Mepyramine is combined with Safrazine"
                    },
                    {
                        "drugbank-id": "DB09254",
                        "description": "The risk or severity of adverse effects can be increased when Mepyramine is combined with Caroxazone"
                    },
                    {
                        "drugbank-id": "DB09286",
                        "description": "The risk or severity of adverse effects can be increased when Mepyramine is combined with Pipamperone"
                    },
                    {
                        "drugbank-id": "DB09289",
                        "description": "The risk or severity of adverse effects can be increased when Mepyramine is combined with Tianeptine"
                    },
                    {
                        "drugbank-id": "DB09290",
                        "description": "The risk or severity of adverse effects can be increased when Mepyramine is combined with Ramosetron"
                    },
                    {
                        "drugbank-id": "DB09307",
                        "description": "The risk or severity of adverse effects can be increased when Mepyramine is combined with Oxaprotiline"
                    },
                    {
                        "drugbank-id": "DB11156",
                        "description": "The risk or severity of adverse effects can be increased when Mepyramine is combined with Pyrantel"
                    },
                    {
                        "drugbank-id": "DB11371",
                        "description": "The risk or severity of adverse effects can be increased when Mepyramine is combined with Alfaxalone"
                    },
                    {
                        "drugbank-id": "DB11376",
                        "description": "The risk or severity of adverse effects can be increased when Mepyramine is combined with Azaperone"
                    },
                    {
                        "drugbank-id": "DB11400",
                        "description": "The risk or severity of adverse effects can be increased when Mepyramine is combined with Doramectin"
                    },
                    {
                        "drugbank-id": "DB11428",
                        "description": "The risk or severity of adverse effects can be increased when Mepyramine is combined with Medetomidine"
                    },
                    {
                        "drugbank-id": "DB11477",
                        "description": "The risk or severity of adverse effects can be increased when Mepyramine is combined with Xylazine"
                    },
                    {
                        "drugbank-id": "DB11540",
                        "description": "The risk or severity of adverse effects can be increased when Mepyramine is combined with Propiopromazine"
                    },
                    {
                        "drugbank-id": "DB11543",
                        "description": "The risk or severity of adverse effects can be increased when Mepyramine is combined with Romifidine"
                    },
                    {
                        "drugbank-id": "DB11549",
                        "description": "The risk or severity of adverse effects can be increased when Mepyramine is combined with Tiletamine"
                    },
                    {
                        "drugbank-id": "DB11552",
                        "description": "The risk or severity of adverse effects can be increased when Mepyramine is combined with Tricaine"
                    },
                    {
                        "drugbank-id": "DB11555",
                        "description": "The risk or severity of adverse effects can be increased when Mepyramine is combined with Zolazepam"
                    },
                    {
                        "drugbank-id": "DB11556",
                        "description": "The risk or severity of adverse effects can be increased when Mepyramine is combined with Detomidine"
                    },
                    {
                        "drugbank-id": "DB11582",
                        "description": "The risk or severity of adverse effects can be increased when Mepyramine is combined with Thiocolchicoside"
                    },
                    {
                        "drugbank-id": "DB11609",
                        "description": "The risk or severity of adverse effects can be increased when Mepyramine is combined with Normethadone"
                    },
                    {
                        "drugbank-id": "DB11664",
                        "description": "The risk or severity of adverse effects can be increased when Mepyramine is combined with Psilocybin"
                    },
                    {
                        "drugbank-id": "DB11675",
                        "description": "The risk or severity of adverse effects can be increased when Mepyramine is combined with Mosapride"
                    },
                    {
                        "drugbank-id": "DB11686",
                        "description": "The risk or severity of adverse effects can be increased when Mepyramine is combined with Iferanserin"
                    },
                    {
                        "drugbank-id": "DB11699",
                        "description": "The risk or severity of adverse effects can be increased when Mepyramine is combined with Tropisetron"
                    },
                    {
                        "drugbank-id": "DB11755",
                        "description": "The risk or severity of adverse effects can be increased when Mepyramine is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB11859",
                        "description": "The risk or severity of adverse effects can be increased when Mepyramine is combined with Brexanolone"
                    },
                    {
                        "drugbank-id": "DB11868",
                        "description": "The risk or severity of adverse effects can be increased when Mepyramine is combined with Etiracetam"
                    },
                    {
                        "drugbank-id": "DB11889",
                        "description": "The risk or severity of adverse effects can be increased when Mepyramine is combined with Lanicemine"
                    },
                    {
                        "drugbank-id": "DB11957",
                        "description": "The risk or severity of adverse effects can be increased when Mepyramine is combined with Idalopirdine"
                    },
                    {
                        "drugbank-id": "DB12071",
                        "description": "The risk or severity of adverse effects can be increased when Mepyramine is combined with Vabicaserin"
                    },
                    {
                        "drugbank-id": "DB12093",
                        "description": "The risk or severity of adverse effects can be increased when Mepyramine is combined with Tetrahydropalmatine"
                    },
                    {
                        "drugbank-id": "DB12105",
                        "description": "The risk or severity of adverse effects can be increased when Mepyramine is combined with Imagabalin"
                    },
                    {
                        "drugbank-id": "DB12110",
                        "description": "The risk or severity of adverse effects can be increased when Mepyramine is combined with m Chlorophenylpiperazine"
                    },
                    {
                        "drugbank-id": "DB12111",
                        "description": "The risk or severity of adverse effects can be increased when Mepyramine is combined with MK 212"
                    },
                    {
                        "drugbank-id": "DB12131",
                        "description": "The risk or severity of adverse effects can be increased when Mepyramine is combined with Vinpocetine"
                    },
                    {
                        "drugbank-id": "DB12163",
                        "description": "The risk or severity of adverse effects can be increased when Mepyramine is combined with Sarpogrelate"
                    },
                    {
                        "drugbank-id": "DB12177",
                        "description": "The risk or severity of adverse effects can be increased when Mepyramine is combined with Eplivanserin"
                    },
                    {
                        "drugbank-id": "DB12184",
                        "description": "The risk or severity of adverse effects can be increased when Mepyramine is combined with Gepirone"
                    },
                    {
                        "drugbank-id": "DB12229",
                        "description": "The risk or severity of adverse effects can be increased when Mepyramine is combined with Cerlapirdine"
                    },
                    {
                        "drugbank-id": "DB12273",
                        "description": "The risk or severity of adverse effects can be increased when Mepyramine is combined with Ecopipam"
                    },
                    {
                        "drugbank-id": "DB12308",
                        "description": "The risk or severity of adverse effects can be increased when Mepyramine is combined with Eltanolone"
                    },
                    {
                        "drugbank-id": "DB12327",
                        "description": "The risk or severity of adverse effects can be increased when Mepyramine is combined with Salvinorin A"
                    },
                    {
                        "drugbank-id": "DB12338",
                        "description": "The risk or severity of adverse effects can be increased when Mepyramine is combined with Carisbamate"
                    },
                    {
                        "drugbank-id": "DB12361",
                        "description": "The risk or severity of adverse effects can be increased when Mepyramine is combined with Piclozotan"
                    },
                    {
                        "drugbank-id": "DB12395",
                        "description": "The risk or severity of adverse effects can be increased when Mepyramine is combined with Esreboxetine"
                    },
                    {
                        "drugbank-id": "DB12401",
                        "description": "The risk or severity of adverse effects can be increased when Mepyramine is combined with Bromperidol"
                    },
                    {
                        "drugbank-id": "DB12427",
                        "description": "The risk or severity of adverse effects can be increased when Mepyramine is combined with Orvepitant"
                    },
                    {
                        "drugbank-id": "DB12465",
                        "description": "The risk or severity of adverse effects can be increased when Mepyramine is combined with Ketanserin"
                    },
                    {
                        "drugbank-id": "DB12492",
                        "description": "The risk or severity of adverse effects can be increased when Mepyramine is combined with Piritramide"
                    },
                    {
                        "drugbank-id": "DB12518",
                        "description": "The risk or severity of adverse effects can be increased when Mepyramine is combined with Raclopride"
                    },
                    {
                        "drugbank-id": "DB12537",
                        "description": "The risk or severity of adverse effects can be increased when Mepyramine is combined with Benzodiazepine"
                    },
                    {
                        "drugbank-id": "DB12576",
                        "description": "The risk or severity of adverse effects can be increased when Mepyramine is combined with AZD 3043"
                    },
                    {
                        "drugbank-id": "DB12590",
                        "description": "The risk or severity of adverse effects can be increased when Mepyramine is combined with Indiplon"
                    },
                    {
                        "drugbank-id": "DB12661",
                        "description": "The risk or severity of adverse effects can be increased when Mepyramine is combined with Urapidil"
                    },
                    {
                        "drugbank-id": "DB12710",
                        "description": "The risk or severity of adverse effects can be increased when Mepyramine is combined with Perazine"
                    },
                    {
                        "drugbank-id": "DB12725",
                        "description": "The risk or severity of adverse effects can be increased when Mepyramine is combined with TD 8954"
                    },
                    {
                        "drugbank-id": "DB12833",
                        "description": "The risk or severity of adverse effects can be increased when Mepyramine is combined with Tandospirone"
                    },
                    {
                        "drugbank-id": "DB12867",
                        "description": "The risk or severity of adverse effects can be increased when Mepyramine is combined with Benperidol"
                    },
                    {
                        "drugbank-id": "DB12883",
                        "description": "The risk or severity of adverse effects can be increased when Mepyramine is combined with Eltoprazine"
                    },
                    {
                        "drugbank-id": "DB12951",
                        "description": "The risk or severity of adverse effects can be increased when Mepyramine is combined with Pivagabine"
                    },
                    {
                        "drugbank-id": "DB12958",
                        "description": "The risk or severity of adverse effects can be increased when Mepyramine is combined with Prothipendyl"
                    },
                    {
                        "drugbank-id": "DB12989",
                        "description": "The risk or severity of adverse effects can be increased when Mepyramine is combined with Neosaxitoxin"
                    },
                    {
                        "drugbank-id": "DB13014",
                        "description": "The risk or severity of adverse effects can be increased when Mepyramine is combined with Hypericin"
                    },
                    {
                        "drugbank-id": "DB13025",
                        "description": "The risk or severity of adverse effects can be increased when Mepyramine is combined with Tiapride"
                    },
                    {
                        "drugbank-id": "DB13082",
                        "description": "The risk or severity of adverse effects can be increased when Mepyramine is combined with Nefiracetam"
                    },
                    {
                        "drugbank-id": "DB13099",
                        "description": "The risk or severity of adverse effects can be increased when Mepyramine is combined with Valnoctamide"
                    },
                    {
                        "drugbank-id": "DB13114",
                        "description": "The risk or severity of adverse effects can be increased when Mepyramine is combined with Amitriptylinoxide"
                    },
                    {
                        "drugbank-id": "DB13160",
                        "description": "The risk or severity of adverse effects can be increased when Mepyramine is combined with Alphaprodine"
                    },
                    {
                        "drugbank-id": "DB13213",
                        "description": "The risk or severity of adverse effects can be increased when Mepyramine is combined with Butaperazine"
                    },
                    {
                        "drugbank-id": "DB13219",
                        "description": "The risk or severity of adverse effects can be increased when Mepyramine is combined with Medifoxamine"
                    },
                    {
                        "drugbank-id": "DB13221",
                        "description": "The risk or severity of adverse effects can be increased when Mepyramine is combined with Apronalide"
                    },
                    {
                        "drugbank-id": "DB13225",
                        "description": "The risk or severity of adverse effects can be increased when Mepyramine is combined with Dibenzepin"
                    },
                    {
                        "drugbank-id": "DB13234",
                        "description": "The risk or severity of adverse effects can be increased when Mepyramine is combined with Propanidid"
                    },
                    {
                        "drugbank-id": "DB13246",
                        "description": "The risk or severity of adverse effects can be increased when Mepyramine is combined with Quinupramine"
                    },
                    {
                        "drugbank-id": "DB13253",
                        "description": "The risk or severity of adverse effects can be increased when Mepyramine is combined with Proxibarbal"
                    },
                    {
                        "drugbank-id": "DB13256",
                        "description": "The risk or severity of adverse effects can be increased when Mepyramine is combined with Clothiapine"
                    },
                    {
                        "drugbank-id": "DB13295",
                        "description": "The risk or severity of adverse effects can be increased when Mepyramine is combined with Atracurium"
                    },
                    {
                        "drugbank-id": "DB13303",
                        "description": "The risk or severity of adverse effects can be increased when Mepyramine is combined with Febarbamate"
                    },
                    {
                        "drugbank-id": "DB13323",
                        "description": "The risk or severity of adverse effects can be increased when Mepyramine is combined with Trichloroethylene"
                    },
                    {
                        "drugbank-id": "DB13324",
                        "description": "The risk or severity of adverse effects can be increased when Mepyramine is combined with Tetrazepam"
                    },
                    {
                        "drugbank-id": "DB13331",
                        "description": "The risk or severity of adverse effects can be increased when Mepyramine is combined with Pyrithyldione"
                    },
                    {
                        "drugbank-id": "DB13335",
                        "description": "The risk or severity of adverse effects can be increased when Mepyramine is combined with Pinazepam"
                    },
                    {
                        "drugbank-id": "DB13352",
                        "description": "The risk or severity of adverse effects can be increased when Mepyramine is combined with Deanol"
                    },
                    {
                        "drugbank-id": "DB13354",
                        "description": "The risk or severity of adverse effects can be increased when Mepyramine is combined with Phenprobamate"
                    },
                    {
                        "drugbank-id": "DB13357",
                        "description": "The risk or severity of adverse effects can be increased when Mepyramine is combined with Styramate"
                    },
                    {
                        "drugbank-id": "DB13362",
                        "description": "The risk or severity of adverse effects can be increased when Mepyramine is combined with Pheneturide"
                    },
                    {
                        "drugbank-id": "DB13370",
                        "description": "The risk or severity of adverse effects can be increased when Mepyramine is combined with Bromisoval"
                    },
                    {
                        "drugbank-id": "DB13377",
                        "description": "The risk or severity of adverse effects can be increased when Mepyramine is combined with Vinbarbital"
                    },
                    {
                        "drugbank-id": "DB13382",
                        "description": "The risk or severity of adverse effects can be increased when Mepyramine is combined with Chlorproethazine"
                    },
                    {
                        "drugbank-id": "DB13384",
                        "description": "The risk or severity of adverse effects can be increased when Mepyramine is combined with Melitracen"
                    },
                    {
                        "drugbank-id": "DB13396",
                        "description": "The risk or severity of adverse effects can be increased when Mepyramine is combined with Neocitrullamon"
                    },
                    {
                        "drugbank-id": "DB13402",
                        "description": "The risk or severity of adverse effects can be increased when Mepyramine is combined with Acetylglycinamide chloral hydrate"
                    },
                    {
                        "drugbank-id": "DB13403",
                        "description": "The risk or severity of adverse effects can be increased when Mepyramine is combined with Oxypertine"
                    },
                    {
                        "drugbank-id": "DB13411",
                        "description": "The risk or severity of adverse effects can be increased when Mepyramine is combined with Lofepramine"
                    },
                    {
                        "drugbank-id": "DB13414",
                        "description": "The risk or severity of adverse effects can be increased when Mepyramine is combined with Fenyramidol"
                    },
                    {
                        "drugbank-id": "DB13420",
                        "description": "The risk or severity of adverse effects can be increased when Mepyramine is combined with Thiazinam"
                    },
                    {
                        "drugbank-id": "DB13437",
                        "description": "The risk or severity of adverse effects can be increased when Mepyramine is combined with Medazepam"
                    },
                    {
                        "drugbank-id": "DB13454",
                        "description": "The risk or severity of adverse effects can be increased when Mepyramine is combined with Nicomorphine"
                    },
                    {
                        "drugbank-id": "DB13455",
                        "description": "The risk or severity of adverse effects can be increased when Mepyramine is combined with Phenibut"
                    },
                    {
                        "drugbank-id": "DB13457",
                        "description": "The risk or severity of adverse effects can be increased when Mepyramine is combined with Oxaflozane"
                    },
                    {
                        "drugbank-id": "DB13478",
                        "description": "The risk or severity of adverse effects can be increased when Mepyramine is combined with Meptazinol"
                    },
                    {
                        "drugbank-id": "DB13496",
                        "description": "The risk or severity of adverse effects can be increased when Mepyramine is combined with Iprindole"
                    },
                    {
                        "drugbank-id": "DB13520",
                        "description": "The risk or severity of adverse effects can be increased when Mepyramine is combined with Metergoline"
                    },
                    {
                        "drugbank-id": "DB13522",
                        "description": "The risk or severity of adverse effects can be increased when Mepyramine is combined with Mebicar"
                    },
                    {
                        "drugbank-id": "DB13523",
                        "description": "The risk or severity of adverse effects can be increased when Mepyramine is combined with Veralipride"
                    },
                    {
                        "drugbank-id": "DB13534",
                        "description": "The risk or severity of adverse effects can be increased when Mepyramine is combined with Gedocarnil"
                    },
                    {
                        "drugbank-id": "DB13541",
                        "description": "The risk or severity of adverse effects can be increased when Mepyramine is combined with Iprazochrome"
                    },
                    {
                        "drugbank-id": "DB13550",
                        "description": "The risk or severity of adverse effects can be increased when Mepyramine is combined with Bifemelane"
                    },
                    {
                        "drugbank-id": "DB13552",
                        "description": "The risk or severity of adverse effects can be increased when Mepyramine is combined with Trifluperidol"
                    },
                    {
                        "drugbank-id": "DB13554",
                        "description": "The risk or severity of adverse effects can be increased when Mepyramine is combined with Moperone"
                    },
                    {
                        "drugbank-id": "DB13557",
                        "description": "The risk or severity of adverse effects can be increased when Mepyramine is combined with Thiopropazate"
                    },
                    {
                        "drugbank-id": "DB13572",
                        "description": "The risk or severity of adverse effects can be increased when Mepyramine is combined with Emylcamate"
                    },
                    {
                        "drugbank-id": "DB13577",
                        "description": "The risk or severity of adverse effects can be increased when Mepyramine is combined with Allobarbital"
                    },
                    {
                        "drugbank-id": "DB13584",
                        "description": "The risk or severity of adverse effects can be increased when Mepyramine is combined with Gallamine"
                    },
                    {
                        "drugbank-id": "DB13588",
                        "description": "The risk or severity of adverse effects can be increased when Mepyramine is combined with Naftidrofuryl"
                    },
                    {
                        "drugbank-id": "DB13598",
                        "description": "The risk or severity of adverse effects can be increased when Mepyramine is combined with Diethyl ether"
                    },
                    {
                        "drugbank-id": "DB13601",
                        "description": "The risk or severity of adverse effects can be increased when Mepyramine is combined with Oxiracetam"
                    },
                    {
                        "drugbank-id": "DB13605",
                        "description": "The risk or severity of adverse effects can be increased when Mepyramine is combined with Phenoperidine"
                    },
                    {
                        "drugbank-id": "DB13606",
                        "description": "The risk or severity of adverse effects can be increased when Mepyramine is combined with Phenazocine"
                    },
                    {
                        "drugbank-id": "DB13623",
                        "description": "The risk or severity of adverse effects can be increased when Mepyramine is combined with Fabomotizole"
                    },
                    {
                        "drugbank-id": "DB13642",
                        "description": "The risk or severity of adverse effects can be increased when Mepyramine is combined with Pridinol"
                    },
                    {
                        "drugbank-id": "DB13643",
                        "description": "The risk or severity of adverse effects can be increased when Mepyramine is combined with Loprazolam"
                    },
                    {
                        "drugbank-id": "DB13648",
                        "description": "The risk or severity of adverse effects can be increased when Mepyramine is combined with Alcuronium"
                    },
                    {
                        "drugbank-id": "DB13662",
                        "description": "The risk or severity of adverse effects can be increased when Mepyramine is combined with Hexapropymate"
                    },
                    {
                        "drugbank-id": "DB13665",
                        "description": "The risk or severity of adverse effects can be increased when Mepyramine is combined with Fluanisone"
                    },
                    {
                        "drugbank-id": "DB13676",
                        "description": "The risk or severity of adverse effects can be increased when Mepyramine is combined with Mosapramine"
                    },
                    {
                        "drugbank-id": "DB13687",
                        "description": "The risk or severity of adverse effects can be increased when Mepyramine is combined with Niaprazine"
                    },
                    {
                        "drugbank-id": "DB13690",
                        "description": "The risk or severity of adverse effects can be increased when Mepyramine is combined with Vinyl ether"
                    },
                    {
                        "drugbank-id": "DB13733",
                        "description": "The risk or severity of adverse effects can be increased when Mepyramine is combined with Methylpentynol"
                    },
                    {
                        "drugbank-id": "DB13737",
                        "description": "The risk or severity of adverse effects can be increased when Mepyramine is combined with Cyclobarbital"
                    },
                    {
                        "drugbank-id": "DB13745",
                        "description": "The risk or severity of adverse effects can be increased when Mepyramine is combined with Fazadinium bromide"
                    },
                    {
                        "drugbank-id": "DB13754",
                        "description": "The risk or severity of adverse effects can be increased when Mepyramine is combined with Mephenoxalone"
                    },
                    {
                        "drugbank-id": "DB13770",
                        "description": "The risk or severity of adverse effects can be increased when Mepyramine is combined with Vinylbital"
                    },
                    {
                        "drugbank-id": "DB13782",
                        "description": "The risk or severity of adverse effects can be increased when Mepyramine is combined with Imipramine oxide"
                    },
                    {
                        "drugbank-id": "DB13784",
                        "description": "The risk or severity of adverse effects can be increased when Mepyramine is combined with Dixyrazine"
                    },
                    {
                        "drugbank-id": "DB13787",
                        "description": "The risk or severity of adverse effects can be increased when Mepyramine is combined with Tilidine"
                    },
                    {
                        "drugbank-id": "DB13799",
                        "description": "The risk or severity of adverse effects can be increased when Mepyramine is combined with Ethadione"
                    },
                    {
                        "drugbank-id": "DB13805",
                        "description": "The risk or severity of adverse effects can be increased when Mepyramine is combined with Reposal"
                    },
                    {
                        "drugbank-id": "DB13817",
                        "description": "The risk or severity of adverse effects can be increased when Mepyramine is combined with Carbromal"
                    },
                    {
                        "drugbank-id": "DB13837",
                        "description": "The risk or severity of adverse effects can be increased when Mepyramine is combined with Doxefazepam"
                    },
                    {
                        "drugbank-id": "DB13841",
                        "description": "The risk or severity of adverse effects can be increased when Mepyramine is combined with Clopenthixol"
                    },
                    {
                        "drugbank-id": "DB13872",
                        "description": "The risk or severity of adverse effects can be increased when Mepyramine is combined with Lormetazepam"
                    },
                    {
                        "drugbank-id": "DB13875",
                        "description": "The risk or severity of adverse effects can be increased when Mepyramine is combined with Harmaline"
                    },
                    {
                        "drugbank-id": "DB13876",
                        "description": "The risk or severity of adverse effects can be increased when Mepyramine is combined with Brofaromine"
                    },
                    {
                        "drugbank-id": "DB13948",
                        "description": "The risk or severity of adverse effects can be increased when Mepyramine is combined with N 2 hydroxybenzyl 2 5 dimethoxy 4 cyanophenylethylamine"
                    },
                    {
                        "drugbank-id": "DB13984",
                        "description": "The risk or severity of adverse effects can be increased when Mepyramine is combined with Cyclopropane"
                    },
                    {
                        "drugbank-id": "DB13993",
                        "description": "The risk or severity of adverse effects can be increased when Mepyramine is combined with MRK 409"
                    },
                    {
                        "drugbank-id": "DB14010",
                        "description": "The risk or severity of adverse effects can be increased when Mepyramine is combined with 5 methoxy N N dimethyltryptamine"
                    },
                    {
                        "drugbank-id": "DB14028",
                        "description": "The risk or severity of adverse effects can be increased when Mepyramine is combined with Nordazepam"
                    },
                    {
                        "drugbank-id": "DB14050",
                        "description": "The risk or severity of adverse effects can be increased when Mepyramine is combined with Cannabidivarin"
                    },
                    {
                        "drugbank-id": "DB14509",
                        "description": "The risk or severity of adverse effects can be increased when Mepyramine is combined with Lithium carbonate"
                    },
                    {
                        "drugbank-id": "DB14575",
                        "description": "The risk or severity of adverse effects can be increased when Mepyramine is combined with Eslicarbazepine"
                    },
                    {
                        "drugbank-id": "DB14651",
                        "description": "The risk or severity of adverse effects can be increased when Mepyramine is combined with Perphenazine enanthate"
                    },
                    {
                        "drugbank-id": "DB14672",
                        "description": "The risk or severity of adverse effects can be increased when Mepyramine is combined with Oxazepam acetate"
                    },
                    {
                        "drugbank-id": "DB14715",
                        "description": "The risk or severity of adverse effects can be increased when Mepyramine is combined with Cinazepam"
                    },
                    {
                        "drugbank-id": "DB14718",
                        "description": "The risk or severity of adverse effects can be increased when Mepyramine is combined with Pyrazolam"
                    },
                    {
                        "drugbank-id": "DB14719",
                        "description": "The risk or severity of adverse effects can be increased when Mepyramine is combined with Bentazepam"
                    },
                    {
                        "drugbank-id": "DB14754",
                        "description": "The risk or severity of adverse effects can be increased when Mepyramine is combined with Solriamfetol"
                    },
                    {
                        "drugbank-id": "DB15203",
                        "description": "The risk or severity of adverse effects can be increased when Mepyramine is combined with JNJ 26489112"
                    },
                    {
                        "drugbank-id": "DB15360",
                        "description": "The risk or severity of adverse effects can be increased when Mepyramine is combined with Carfentanil C 11"
                    },
                    {
                        "drugbank-id": "DB00216",
                        "description": "The risk or severity of adverse effects can be increased when Eletriptan is combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB00285",
                        "description": "The risk or severity of adverse effects can be increased when Venlafaxine is combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB00295",
                        "description": "The risk or severity of adverse effects can be increased when Morphine is combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB00356",
                        "description": "The risk or severity of adverse effects can be increased when Chlorzoxazone is combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB00377",
                        "description": "The risk or severity of adverse effects can be increased when Palonosetron is combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB00409",
                        "description": "The risk or severity of adverse effects can be increased when Remoxipride is combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB00433",
                        "description": "The risk or severity of adverse effects can be increased when Prochlorperazine is combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB00497",
                        "description": "The risk or severity of adverse effects can be increased when Oxycodone is combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB00589",
                        "description": "The risk or severity of adverse effects can be increased when Lisuride is combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB00647",
                        "description": "The risk or severity of adverse effects can be increased when Dextropropoxyphene is combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB00734",
                        "description": "The risk or severity of adverse effects can be increased when Risperidone is combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB00737",
                        "description": "The risk or severity of adverse effects can be increased when Meclizine is combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB00757",
                        "description": "The risk or severity of adverse effects can be increased when Dolasetron is combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB00805",
                        "description": "The risk or severity of adverse effects can be increased when Minaprine is combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB00843",
                        "description": "The risk or severity of adverse effects can be increased when Donepezil is combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB00850",
                        "description": "The risk or severity of adverse effects can be increased when Perphenazine is combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB00866",
                        "description": "The risk or severity of adverse effects can be increased when Alprenolol is combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB00904",
                        "description": "The risk or severity of adverse effects can be increased when Ondansetron is combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB00918",
                        "description": "The risk or severity of adverse effects can be increased when Almotriptan is combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB00933",
                        "description": "The risk or severity of adverse effects can be increased when Mesoridazine is combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB00960",
                        "description": "The risk or severity of adverse effects can be increased when Pindolol is combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB01028",
                        "description": "The risk or severity of adverse effects can be increased when Methoxyflurane is combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB01037",
                        "description": "The risk or severity of adverse effects can be increased when Selegiline is combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB01114",
                        "description": "The risk or severity of adverse effects can be increased when Chlorpheniramine is combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB01156",
                        "description": "The risk or severity of adverse effects can be increased when Bupropion is combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB01171",
                        "description": "The risk or severity of adverse effects can be increased when Moclobemide is combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB01192",
                        "description": "The risk or severity of adverse effects can be increased when Oxymorphone is combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB01359",
                        "description": "The risk or severity of adverse effects can be increased when Penbutolol is combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB01392",
                        "description": "The risk or severity of adverse effects can be increased when Yohimbine is combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB01466",
                        "description": "The risk or severity of adverse effects can be increased when Ethylmorphine is combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB01472",
                        "description": "The risk or severity of adverse effects can be increased when 4 Methoxyamphetamine is combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB01551",
                        "description": "The risk or severity of adverse effects can be increased when Dihydrocodeine is combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB01580",
                        "description": "The risk or severity of adverse effects can be increased when Oxprenolol is combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB01621",
                        "description": "The risk or severity of adverse effects can be increased when Pipotiazine is combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB04829",
                        "description": "The risk or severity of adverse effects can be increased when Lysergic acid diethylamide is combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB04841",
                        "description": "The risk or severity of adverse effects can be increased when Flunarizine is combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB04871",
                        "description": "The risk or severity of adverse effects can be increased when Lorcaserin is combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB06016",
                        "description": "The risk or severity of adverse effects can be increased when Cariprazine is combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB06144",
                        "description": "The risk or severity of adverse effects can be increased when Sertindole is combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB06148",
                        "description": "The risk or severity of adverse effects can be increased when Mianserin is combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB06678",
                        "description": "The risk or severity of adverse effects can be increased when Esmirtazapine is combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB06684",
                        "description": "The risk or severity of adverse effects can be increased when Vilazodone is combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB06770",
                        "description": "The risk or severity of adverse effects can be increased when Mepyramine is combined with Benzyl alcohol"
                    },
                    {
                        "drugbank-id": "DB08922",
                        "description": "The risk or severity of adverse effects can be increased when Mepyramine is combined with Perospirone"
                    },
                    {
                        "drugbank-id": "DB09068",
                        "description": "The risk or severity of adverse effects can be increased when Mepyramine is combined with Vortioxetine"
                    },
                    {
                        "drugbank-id": "DB09128",
                        "description": "The risk or severity of adverse effects can be increased when Mepyramine is combined with Brexpiprazole"
                    },
                    {
                        "drugbank-id": "DB11130",
                        "description": "The risk or severity of adverse effects can be increased when Mepyramine is combined with Opium"
                    },
                    {
                        "drugbank-id": "DB14185",
                        "description": "The risk or severity of adverse effects can be increased when Mepyramine is combined with Aripiprazole lauroxil"
                    },
                    {
                        "drugbank-id": "DB11951",
                        "description": "The risk or severity of adverse effects can be increased when Mepyramine is combined with Lemborexant"
                    },
                    {
                        "drugbank-id": "DB00344",
                        "description": "The risk or severity of adverse effects can be increased when Protriptyline is combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB00454",
                        "description": "The risk or severity of adverse effects can be increased when Meperidine is combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB00532",
                        "description": "The risk or severity of adverse effects can be increased when Mephenytoin is combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB12930",
                        "description": "The risk or severity of adverse effects can be increased when Mepyramine is combined with Opipramol"
                    },
                    {
                        "drugbank-id": "DB12404",
                        "description": "The risk or severity of adverse effects can be increased when Mepyramine is combined with Remimazolam"
                    },
                    {
                        "drugbank-id": "DB00751",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB00230",
                        "description": "The therapeutic efficacy of Mepyramine can be increased when used in combination with Pregabalin"
                    },
                    {
                        "drugbank-id": "DB08881",
                        "description": "The risk or severity of QTc prolongation can be increased when Mepyramine is combined with Vemurafenib"
                    },
                    {
                        "drugbank-id": "DB11637",
                        "description": "Mepyramine may increase the QTc prolonging activities of Delamanid"
                    },
                    {
                        "drugbank-id": "DB11642",
                        "description": "The therapeutic efficacy of Pitolisant can be decreased when used in combination with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB04844",
                        "description": "The risk or severity of sedation and somnolence can be increased when Mepyramine is combined with Tetrabenazine"
                    },
                    {
                        "drugbank-id": "DB12161",
                        "description": "The risk or severity of sedation and somnolence can be increased when Mepyramine is combined with Deutetrabenazine"
                    },
                    {
                        "drugbank-id": "DB04948",
                        "description": "The therapeutic efficacy of Mepyramine can be increased when used in combination with Lofexidine"
                    },
                    {
                        "drugbank-id": "DB00104",
                        "description": "The risk or severity of QTc prolongation can be increased when Octreotide is combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB00107",
                        "description": "The risk or severity of QTc prolongation can be increased when Oxytocin is combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB00196",
                        "description": "The risk or severity of QTc prolongation can be increased when Fluconazole is combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB00220",
                        "description": "The risk or severity of QTc prolongation can be increased when Nelfinavir is combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB00270",
                        "description": "The risk or severity of QTc prolongation can be increased when Isradipine is combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB00346",
                        "description": "The risk or severity of QTc prolongation can be increased when Alfuzosin is combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB00358",
                        "description": "The risk or severity of QTc prolongation can be increased when Mefloquine is combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB00374",
                        "description": "The risk or severity of QTc prolongation can be increased when Treprostinil is combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB00390",
                        "description": "The risk or severity of QTc prolongation can be increased when Digoxin is combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB00398",
                        "description": "The risk or severity of QTc prolongation can be increased when Sorafenib is combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB00467",
                        "description": "The risk or severity of QTc prolongation can be increased when Enoxacin is combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB00487",
                        "description": "The risk or severity of QTc prolongation can be increased when Pefloxacin is combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB00529",
                        "description": "The risk or severity of QTc prolongation can be increased when Foscarnet is combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB00582",
                        "description": "The risk or severity of QTc prolongation can be increased when Voriconazole is combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB00613",
                        "description": "The risk or severity of QTc prolongation can be increased when Amodiaquine is combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB00678",
                        "description": "The risk or severity of QTc prolongation can be increased when Losartan is combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB00691",
                        "description": "The risk or severity of QTc prolongation can be increased when Moexipril is combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB00710",
                        "description": "The risk or severity of QTc prolongation can be increased when Ibandronate is combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB00719",
                        "description": "The risk or severity of QTc prolongation can be increased when Azatadine is combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB00808",
                        "description": "The risk or severity of QTc prolongation can be increased when Indapamide is combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB00817",
                        "description": "The risk or severity of QTc prolongation can be increased when Rosoxacin is combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB00822",
                        "description": "The risk or severity of QTc prolongation can be increased when Disulfiram is combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB00862",
                        "description": "The risk or severity of QTc prolongation can be increased when Vardenafil is combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB00864",
                        "description": "The risk or severity of QTc prolongation can be increased when Tacrolimus is combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB00871",
                        "description": "The risk or severity of QTc prolongation can be increased when Terbutaline is combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB00915",
                        "description": "The risk or severity of QTc prolongation can be increased when Amantadine is combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB00916",
                        "description": "The risk or severity of QTc prolongation can be increased when Metronidazole is combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB00920",
                        "description": "The risk or severity of QTc prolongation can be increased when Ketotifen is combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB00927",
                        "description": "The risk or severity of QTc prolongation can be increased when Famotidine is combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB00938",
                        "description": "The risk or severity of QTc prolongation can be increased when Salmeterol is combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB00999",
                        "description": "The risk or severity of QTc prolongation can be increased when Hydrochlorothiazide is combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB01001",
                        "description": "The risk or severity of QTc prolongation can be increased when Salbutamol is combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB01015",
                        "description": "The risk or severity of QTc prolongation can be increased when Sulfamethoxazole is combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB01023",
                        "description": "The risk or severity of QTc prolongation can be increased when Felodipine is combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB01026",
                        "description": "The risk or severity of QTc prolongation can be increased when Ketoconazole is combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB01044",
                        "description": "The risk or severity of QTc prolongation can be increased when Gatifloxacin is combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB01054",
                        "description": "The risk or severity of QTc prolongation can be increased when Nitrendipine is combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB01059",
                        "description": "The risk or severity of QTc prolongation can be increased when Norfloxacin is combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB01072",
                        "description": "The risk or severity of QTc prolongation can be increased when Atazanavir is combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB01106",
                        "description": "The risk or severity of QTc prolongation can be increased when Levocabastine is combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB01158",
                        "description": "The risk or severity of QTc prolongation can be increased when Bretylium is combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB01167",
                        "description": "The risk or severity of QTc prolongation can be increased when Itraconazole is combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB01254",
                        "description": "The risk or severity of QTc prolongation can be increased when Dasatinib is combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB01259",
                        "description": "The risk or severity of QTc prolongation can be increased when Lapatinib is combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB01263",
                        "description": "The risk or severity of QTc prolongation can be increased when Posaconazole is combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB01268",
                        "description": "The risk or severity of QTc prolongation can be increased when Sunitinib is combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB01396",
                        "description": "The risk or severity of QTc prolongation can be increased when Digitoxin is combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB01426",
                        "description": "The risk or severity of QTc prolongation can be increased when Ajmaline is combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB01611",
                        "description": "The risk or severity of QTc prolongation can be increased when Hydroxychloroquine is combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB02546",
                        "description": "The risk or severity of QTc prolongation can be increased when Vorinostat is combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB04576",
                        "description": "The risk or severity of QTc prolongation can be increased when Fleroxacin is combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB04695",
                        "description": "The risk or severity of QTc prolongation can be increased when Farnesyl thiopyrophosphate is combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB05039",
                        "description": "The risk or severity of QTc prolongation can be increased when Indacaterol is combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB05465",
                        "description": "The risk or severity of QTc prolongation can be increased when Tandutinib is combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB06468",
                        "description": "The risk or severity of QTc prolongation can be increased when Cariporide is combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB06663",
                        "description": "The risk or severity of QTc prolongation can be increased when Pasireotide is combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB06699",
                        "description": "The risk or severity of QTc prolongation can be increased when Mepyramine is combined with Degarelix"
                    },
                    {
                        "drugbank-id": "DB06719",
                        "description": "The risk or severity of QTc prolongation can be increased when Mepyramine is combined with Buserelin"
                    },
                    {
                        "drugbank-id": "DB06788",
                        "description": "The risk or severity of QTc prolongation can be increased when Mepyramine is combined with Histrelin"
                    },
                    {
                        "drugbank-id": "DB06825",
                        "description": "The risk or severity of QTc prolongation can be increased when Mepyramine is combined with Triptorelin"
                    },
                    {
                        "drugbank-id": "DB07780",
                        "description": "The risk or severity of QTc prolongation can be increased when Mepyramine is combined with Farnesyl diphosphate"
                    },
                    {
                        "drugbank-id": "DB07841",
                        "description": "The risk or severity of QTc prolongation can be increased when Mepyramine is combined with Geranylgeranyl diphosphate"
                    },
                    {
                        "drugbank-id": "DB08864",
                        "description": "The risk or severity of QTc prolongation can be increased when Mepyramine is combined with Rilpivirine"
                    },
                    {
                        "drugbank-id": "DB08871",
                        "description": "The risk or severity of QTc prolongation can be increased when Mepyramine is combined with Eribulin"
                    },
                    {
                        "drugbank-id": "DB08912",
                        "description": "The risk or severity of QTc prolongation can be increased when Mepyramine is combined with Dabrafenib"
                    },
                    {
                        "drugbank-id": "DB08936",
                        "description": "The risk or severity of QTc prolongation can be increased when Mepyramine is combined with Chlorcyclizine"
                    },
                    {
                        "drugbank-id": "DB08972",
                        "description": "The risk or severity of QTc prolongation can be increased when Mepyramine is combined with Flumequine"
                    },
                    {
                        "drugbank-id": "DB09080",
                        "description": "The risk or severity of QTc prolongation can be increased when Mepyramine is combined with Olodaterol"
                    },
                    {
                        "drugbank-id": "DB09082",
                        "description": "The risk or severity of QTc prolongation can be increased when Mepyramine is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB09090",
                        "description": "The risk or severity of QTc prolongation can be increased when Mepyramine is combined with Pinaverium"
                    },
                    {
                        "drugbank-id": "DB09229",
                        "description": "The risk or severity of QTc prolongation can be increased when Mepyramine is combined with Aranidipine"
                    },
                    {
                        "drugbank-id": "DB09235",
                        "description": "The risk or severity of QTc prolongation can be increased when Mepyramine is combined with Efonidipine"
                    },
                    {
                        "drugbank-id": "DB09236",
                        "description": "The risk or severity of QTc prolongation can be increased when Mepyramine is combined with Lacidipine"
                    },
                    {
                        "drugbank-id": "DB09239",
                        "description": "The risk or severity of QTc prolongation can be increased when Mepyramine is combined with Niguldipine"
                    },
                    {
                        "drugbank-id": "DB09488",
                        "description": "The risk or severity of QTc prolongation can be increased when Mepyramine is combined with Acrivastine"
                    },
                    {
                        "drugbank-id": "DB11390",
                        "description": "The risk or severity of QTc prolongation can be increased when Mepyramine is combined with Coumaphos"
                    },
                    {
                        "drugbank-id": "DB11397",
                        "description": "The risk or severity of QTc prolongation can be increased when Mepyramine is combined with Dichlorvos"
                    },
                    {
                        "drugbank-id": "DB11408",
                        "description": "The risk or severity of QTc prolongation can be increased when Mepyramine is combined with Famphur"
                    },
                    {
                        "drugbank-id": "DB11412",
                        "description": "The risk or severity of QTc prolongation can be increased when Mepyramine is combined with Fenthion"
                    },
                    {
                        "drugbank-id": "DB11443",
                        "description": "The risk or severity of QTc prolongation can be increased when Mepyramine is combined with Orbifloxacin"
                    },
                    {
                        "drugbank-id": "DB11448",
                        "description": "The risk or severity of QTc prolongation can be increased when Mepyramine is combined with Phosmet"
                    },
                    {
                        "drugbank-id": "DB11491",
                        "description": "The risk or severity of QTc prolongation can be increased when Mepyramine is combined with Sarafloxacin"
                    },
                    {
                        "drugbank-id": "DB11511",
                        "description": "The risk or severity of QTc prolongation can be increased when Mepyramine is combined with Difloxacin"
                    },
                    {
                        "drugbank-id": "DB11591",
                        "description": "The risk or severity of QTc prolongation can be increased when Mepyramine is combined with Bilastine"
                    },
                    {
                        "drugbank-id": "DB11742",
                        "description": "The risk or severity of QTc prolongation can be increased when Mepyramine is combined with Ebastine"
                    },
                    {
                        "drugbank-id": "DB11774",
                        "description": "The risk or severity of QTc prolongation can be increased when Mepyramine is combined with Pazufloxacin"
                    },
                    {
                        "drugbank-id": "DB11891",
                        "description": "The risk or severity of QTc prolongation can be increased when Mepyramine is combined with CUDC 907"
                    },
                    {
                        "drugbank-id": "DB11892",
                        "description": "The risk or severity of QTc prolongation can be increased when Mepyramine is combined with Prulifloxacin"
                    },
                    {
                        "drugbank-id": "DB11943",
                        "description": "The risk or severity of QTc prolongation can be increased when Mepyramine is combined with Delafloxacin"
                    },
                    {
                        "drugbank-id": "DB12231",
                        "description": "The risk or severity of QTc prolongation can be increased when Mepyramine is combined with Temefos"
                    },
                    {
                        "drugbank-id": "DB12645",
                        "description": "The risk or severity of QTc prolongation can be increased when Mepyramine is combined with Givinostat"
                    },
                    {
                        "drugbank-id": "DB12712",
                        "description": "The risk or severity of QTc prolongation can be increased when Mepyramine is combined with Pilsicainide"
                    },
                    {
                        "drugbank-id": "DB12766",
                        "description": "The risk or severity of QTc prolongation can be increased when Mepyramine is combined with Cicletanine"
                    },
                    {
                        "drugbank-id": "DB12923",
                        "description": "The risk or severity of QTc prolongation can be increased when Mepyramine is combined with Gallopamil"
                    },
                    {
                        "drugbank-id": "DB13358",
                        "description": "The risk or severity of QTc prolongation can be increased when Mepyramine is combined with Cibenzoline"
                    },
                    {
                        "drugbank-id": "DB13488",
                        "description": "The risk or severity of QTc prolongation can be increased when Mepyramine is combined with Bencyclane"
                    },
                    {
                        "drugbank-id": "DB13555",
                        "description": "The risk or severity of QTc prolongation can be increased when Mepyramine is combined with Prajmaline"
                    },
                    {
                        "drugbank-id": "DB13627",
                        "description": "The risk or severity of QTc prolongation can be increased when Mepyramine is combined with Oxolinic acid"
                    },
                    {
                        "drugbank-id": "DB13651",
                        "description": "The risk or severity of QTc prolongation can be increased when Mepyramine is combined with Lorajmine"
                    },
                    {
                        "drugbank-id": "DB13691",
                        "description": "The risk or severity of QTc prolongation can be increased when Mepyramine is combined with Acetyldigoxin"
                    },
                    {
                        "drugbank-id": "DB13744",
                        "description": "The risk or severity of QTc prolongation can be increased when Mepyramine is combined with Piromidic acid"
                    },
                    {
                        "drugbank-id": "DB13766",
                        "description": "The risk or severity of QTc prolongation can be increased when Mepyramine is combined with Lidoflazine"
                    },
                    {
                        "drugbank-id": "DB13772",
                        "description": "The risk or severity of QTc prolongation can be increased when Mepyramine is combined with Rufloxacin"
                    },
                    {
                        "drugbank-id": "DB13823",
                        "description": "The risk or severity of QTc prolongation can be increased when Mepyramine is combined with Pipemidic acid"
                    },
                    {
                        "drugbank-id": "DB14713",
                        "description": "The risk or severity of QTc prolongation can be increased when Mepyramine is combined with Inotersen"
                    },
                    {
                        "drugbank-id": "DB01601",
                        "description": "The risk or severity of QTc prolongation can be increased when Lopinavir is combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB00845",
                        "description": "The risk or severity of QTc prolongation can be increased when Clofazimine is combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB11796",
                        "description": "The risk or severity of QTc prolongation can be increased when Mepyramine is combined with Fostemsavir"
                    },
                    {
                        "drugbank-id": "DB11853",
                        "description": "The risk or severity of QTc prolongation can be increased when Mepyramine is combined with Relugolix"
                    },
                    {
                        "drugbank-id": "DB00245",
                        "description": "The metabolism of Benzatropine can be decreased when combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB00334",
                        "description": "The metabolism of Olanzapine can be decreased when combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB00363",
                        "description": "The metabolism of Clozapine can be decreased when combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB00420",
                        "description": "The metabolism of Promazine can be decreased when combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB00477",
                        "description": "The metabolism of Chlorpromazine can be decreased when combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB00496",
                        "description": "The metabolism of Darifenacin can be decreased when combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB00934",
                        "description": "The metabolism of Maprotiline can be decreased when combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB01036",
                        "description": "The metabolism of Tolterodine can be decreased when combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB01069",
                        "description": "The metabolism of Promethazine can be decreased when combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB01075",
                        "description": "The metabolism of Diphenhydramine can be decreased when combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB01224",
                        "description": "The metabolism of Quetiapine can be decreased when combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB01238",
                        "description": "The metabolism of Aripiprazole can be decreased when combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB01409",
                        "description": "The metabolism of Tiotropium can be decreased when combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB01591",
                        "description": "The metabolism of Solifenacin can be decreased when combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB06702",
                        "description": "The metabolism of Fesoterodine can be decreased when combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB09076",
                        "description": "The metabolism of Umeclidinium can be decreased when combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB11855",
                        "description": "The metabolism of Revefenacin can be decreased when combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB00184",
                        "description": "The metabolism of Nicotine can be decreased when combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB00185",
                        "description": "The metabolism of Cevimeline can be decreased when combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB00187",
                        "description": "The metabolism of Esmolol can be decreased when combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB00188",
                        "description": "The metabolism of Bortezomib can be decreased when combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB00195",
                        "description": "The metabolism of Betaxolol can be decreased when combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB00203",
                        "description": "The metabolism of Sildenafil can be decreased when combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB00208",
                        "description": "The metabolism of Ticlopidine can be decreased when combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB00238",
                        "description": "The metabolism of Nevirapine can be decreased when combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB00243",
                        "description": "The metabolism of Ranolazine can be decreased when combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB00264",
                        "description": "The metabolism of Metoprolol can be decreased when combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB00281",
                        "description": "The metabolism of Lidocaine can be decreased when combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB00297",
                        "description": "The metabolism of Bupivacaine can be decreased when combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB00317",
                        "description": "The metabolism of Gefitinib can be decreased when combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB00335",
                        "description": "The metabolism of Atenolol can be decreased when combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB00343",
                        "description": "The metabolism of Diltiazem can be decreased when combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB00379",
                        "description": "The metabolism of Mexiletine can be decreased when combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB00396",
                        "description": "The metabolism of Progesterone can be decreased when combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB00482",
                        "description": "The metabolism of Celecoxib can be decreased when combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB00490",
                        "description": "The metabolism of Buspirone can be decreased when combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB00503",
                        "description": "The metabolism of Ritonavir can be decreased when combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB00568",
                        "description": "The metabolism of Cinnarizine can be decreased when combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB00571",
                        "description": "The metabolism of Propranolol can be decreased when combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB00590",
                        "description": "The metabolism of Doxazosin can be decreased when combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB00592",
                        "description": "The metabolism of Piperazine can be decreased when combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB00598",
                        "description": "The metabolism of Labetalol can be decreased when combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB00608",
                        "description": "The metabolism of Chloroquine can be decreased when combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB00641",
                        "description": "The metabolism of Simvastatin can be decreased when combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB00674",
                        "description": "The metabolism of Galantamine can be decreased when combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB00699",
                        "description": "The metabolism of Nicergoline can be decreased when combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB00701",
                        "description": "The metabolism of Amprenavir can be decreased when combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB00705",
                        "description": "The metabolism of Delavirdine can be decreased when combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB00706",
                        "description": "The metabolism of Tamsulosin can be decreased when combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB00731",
                        "description": "The metabolism of Nateglinide can be decreased when combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB00738",
                        "description": "The metabolism of Pentamidine can be decreased when combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB00836",
                        "description": "The metabolism of Loperamide can be decreased when combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB00914",
                        "description": "The metabolism of Phenformin can be decreased when combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB00932",
                        "description": "The metabolism of Tipranavir can be decreased when combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB00983",
                        "description": "The metabolism of Formoterol can be decreased when combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB01071",
                        "description": "The metabolism of Mequitazine can be decreased when combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB01074",
                        "description": "The metabolism of Perhexiline can be decreased when combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB01079",
                        "description": "The metabolism of Tegaserod can be decreased when combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB01095",
                        "description": "The metabolism of Fluvastatin can be decreased when combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB01115",
                        "description": "The metabolism of Nifedipine can be decreased when combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB01136",
                        "description": "The metabolism of Carvedilol can be decreased when combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB01166",
                        "description": "The metabolism of Cilostazol can be decreased when combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB01177",
                        "description": "The metabolism of Idarubicin can be decreased when combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB01182",
                        "description": "The metabolism of Propafenone can be decreased when combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB01191",
                        "description": "The metabolism of Dexfenfluramine can be decreased when combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB01193",
                        "description": "The metabolism of Acebutolol can be decreased when combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB01203",
                        "description": "The metabolism of Nadolol can be decreased when combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB01228",
                        "description": "The metabolism of Encainide can be decreased when combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB01274",
                        "description": "The metabolism of Arformoterol can be decreased when combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB01295",
                        "description": "The metabolism of Bevantolol can be decreased when combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB01297",
                        "description": "The metabolism of Practolol can be decreased when combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB01424",
                        "description": "The metabolism of Aminophenazone can be decreased when combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB01429",
                        "description": "The metabolism of Aprindine can be decreased when combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB01435",
                        "description": "The metabolism of Antipyrine can be decreased when combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB02703",
                        "description": "The metabolism of Fusidic acid can be decreased when combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB03783",
                        "description": "The metabolism of Phenacetin can be decreased when combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB04840",
                        "description": "The metabolism of Debrisoquine can be decreased when combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB04846",
                        "description": "The metabolism of Celiprolol can be decreased when combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB04861",
                        "description": "The metabolism of Nebivolol can be decreased when combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB04905",
                        "description": "The metabolism of Tesmilifene can be decreased when combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB04920",
                        "description": "The metabolism of Clevidipine can be decreased when combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB06203",
                        "description": "The metabolism of Alogliptin can be decreased when combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB06217",
                        "description": "The metabolism of Vernakalant can be decreased when combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB06292",
                        "description": "The metabolism of Dapagliflozin can be decreased when combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB06506",
                        "description": "The metabolism of Repinotan can be decreased when combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB06589",
                        "description": "The metabolism of Pazopanib can be decreased when combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB06608",
                        "description": "The metabolism of Tafenoquine can be decreased when combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB06726",
                        "description": "The metabolism of Bufuralol can be decreased when combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB06727",
                        "description": "The metabolism of Sparteine can be decreased when combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB06735",
                        "description": "The metabolism of Enclomiphene can be decreased when combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB08807",
                        "description": "The metabolism of Bopindolol can be decreased when combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB08808",
                        "description": "The metabolism of Bupranolol can be decreased when combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB08893",
                        "description": "The metabolism of Mirabegron can be decreased when combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB08952",
                        "description": "The metabolism of Indenolol can be decreased when combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB09048",
                        "description": "The metabolism of Netupitant can be decreased when combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB09053",
                        "description": "The metabolism of Ibrutinib can be decreased when combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB09173",
                        "description": "The metabolism of Butyrfentanyl can be decreased when combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB09183",
                        "description": "The metabolism of Dasabuvir can be decreased when combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB09195",
                        "description": "The metabolism of Lorpiprazole can be decreased when combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB09204",
                        "description": "The metabolism of Arotinolol can be decreased when combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB09288",
                        "description": "The metabolism of Propacetamol can be decreased when combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB09351",
                        "description": "The metabolism of Levobetaxolol can be decreased when combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB09555",
                        "description": "The metabolism of Dexchlorpheniramine maleate can be decreased when combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB11586",
                        "description": "The metabolism of Asunaprevir can be decreased when combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB11614",
                        "description": "The metabolism of Rupatadine can be decreased when combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB11757",
                        "description": "The metabolism of Istradefylline can be decreased when combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB11770",
                        "description": "The metabolism of Talinolol can be decreased when combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB11785",
                        "description": "The metabolism of Anisodamine can be decreased when combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB11915",
                        "description": "The metabolism of Valbenazine can be decreased when combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB11979",
                        "description": "The metabolism of Elagolix can be decreased when combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB12070",
                        "description": "The metabolism of Letermovir can be decreased when combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB12212",
                        "description": "The metabolism of Landiolol can be decreased when combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB12245",
                        "description": "The metabolism of Triclabendazole can be decreased when combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB12332",
                        "description": "The metabolism of Rucaparib can be decreased when combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB12752",
                        "description": "The metabolism of Bucindolol can be decreased when combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB13293",
                        "description": "The metabolism of Ipecac can be decreased when combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB13443",
                        "description": "The metabolism of Esatenolol can be decreased when combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB13508",
                        "description": "The metabolism of Cloranolol can be decreased when combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB13530",
                        "description": "The metabolism of Mepindolol can be decreased when combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB13679",
                        "description": "The metabolism of Dexchlorpheniramine can be decreased when combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB13757",
                        "description": "The metabolism of Epanolol can be decreased when combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB13775",
                        "description": "The metabolism of Tertatolol can be decreased when combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB01410",
                        "description": "The metabolism of Ciclesonide can be decreased when combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB04889",
                        "description": "The metabolism of Bicifadine can be decreased when combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB11718",
                        "description": "The metabolism of Encorafenib can be decreased when combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB01100",
                        "description": "The metabolism of Pimozide can be decreased when combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB09167",
                        "description": "The metabolism of Dosulepin can be decreased when combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB00489",
                        "description": "The metabolism of Sotalol can be decreased when combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB00530",
                        "description": "The metabolism of Erlotinib can be decreased when combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB00637",
                        "description": "The metabolism of Astemizole can be decreased when combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB00675",
                        "description": "The metabolism of Tamoxifen can be decreased when combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB01035",
                        "description": "The metabolism of Procainamide can be decreased when combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB01195",
                        "description": "The metabolism of Flecainide can be decreased when combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB05109",
                        "description": "The metabolism of Trabectedin can be decreased when combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB08901",
                        "description": "The metabolism of Ponatinib can be decreased when combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB11963",
                        "description": "The metabolism of Dacomitinib can be decreased when combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB13874",
                        "description": "The metabolism of Enasidenib can be decreased when combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB00458",
                        "description": "The metabolism of Imipramine can be decreased when combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB00540",
                        "description": "The metabolism of Nortriptyline can be decreased when combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB00543",
                        "description": "The metabolism of Amoxapine can be decreased when combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB01151",
                        "description": "The metabolism of Desipramine can be decreased when combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB00726",
                        "description": "The metabolism of Mepyramine can be decreased when combined with Trimipramine"
                    },
                    {
                        "drugbank-id": "DB01242",
                        "description": "The metabolism of Mepyramine can be decreased when combined with Clomipramine"
                    },
                    {
                        "drugbank-id": "DB05077",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB06155",
                        "description": "The risk or severity of adverse effects can be increased when Rimonabant is combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB06624",
                        "description": "The risk or severity of adverse effects can be increased when Taranabant is combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB09061",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB11903",
                        "description": "The risk or severity of adverse effects can be increased when GW842166 is combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB12193",
                        "description": "The risk or severity of adverse effects can be increased when Ajulemic acid is combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB12649",
                        "description": "The risk or severity of adverse effects can be increased when Ibipinabant is combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB13070",
                        "description": "The risk or severity of adverse effects can be increased when Surinabant is combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB13950",
                        "description": "The risk or severity of adverse effects can be increased when WIN 55212 2 is combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB14011",
                        "description": "The risk or severity of adverse effects can be increased when Nabiximols is combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB14043",
                        "description": "The risk or severity of adverse effects can be increased when Palmidrol is combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB14737",
                        "description": "The risk or severity of adverse effects can be increased when Cannabinol is combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB00368",
                        "description": "The therapeutic efficacy of Norepinephrine can be increased when used in combination with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB00668",
                        "description": "The therapeutic efficacy of Epinephrine can be increased when used in combination with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB06262",
                        "description": "The therapeutic efficacy of Droxidopa can be increased when used in combination with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB06707",
                        "description": "The therapeutic efficacy of Levonordefrin can be increased when used in combination with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB06814",
                        "description": "The therapeutic efficacy of Protokylol can be increased when used in combination with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB11124",
                        "description": "The therapeutic efficacy of Racepinephrine can be increased when used in combination with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB12927",
                        "description": "The therapeutic efficacy of Theodrenaline can be increased when used in combination with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB13917",
                        "description": "The therapeutic efficacy of Deoxyepinephrine can be increased when used in combination with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB00321",
                        "description": "The metabolism of Amitriptyline can be decreased when combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB11823",
                        "description": "The risk or severity of adverse effects can be increased when Mepyramine is combined with Esketamine"
                    },
                    {
                        "drugbank-id": "DB00395",
                        "description": "The risk or severity of adverse effects can be increased when Carisoprodol is combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB06711",
                        "description": "The risk or severity of CNS depression can be increased when Naphazoline is combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB00373",
                        "description": "The metabolism of Timolol can be decreased when combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB00402",
                        "description": "The risk or severity of CNS depression can be increased when Mepyramine is combined with Eszopiclone"
                    },
                    {
                        "drugbank-id": "DB00575",
                        "description": "The risk or severity of sedation can be increased when Clonidine is combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB00656",
                        "description": "The risk or severity of QTc prolongation can be increased when Trazodone is combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB11986",
                        "description": "The risk or severity of QTc prolongation can be increased when Mepyramine is combined with Entrectinib"
                    },
                    {
                        "drugbank-id": "DB12825",
                        "description": "Lefamulin may increase the QTc prolonging activities of Mepyramine"
                    },
                    {
                        "drugbank-id": "DB00924",
                        "description": "The risk or severity of CNS depression can be increased when Mepyramine is combined with Cyclobenzaprine"
                    },
                    {
                        "drugbank-id": "DB01233",
                        "description": "The risk or severity of sedation can be increased when Mepyramine is combined with Metoclopramide"
                    },
                    {
                        "drugbank-id": "DB11732",
                        "description": "The risk or severity of adverse effects can be increased when Mepyramine is combined with Lasmiditan"
                    },
                    {
                        "drugbank-id": "DB00557",
                        "description": "The risk or severity of QTc prolongation can be increased when Hydroxyzine is combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB00193",
                        "description": "The metabolism of Tramadol can be decreased when combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB00246",
                        "description": "The risk or severity of QTc prolongation can be increased when Mepyramine is combined with Ziprasidone"
                    },
                    {
                        "drugbank-id": "DB00502",
                        "description": "The risk or severity of QTc prolongation can be increased when Haloperidol is combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB06283",
                        "description": "The risk or severity of CNS depression can be increased when Ziconotide is combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB00472",
                        "description": "Mepyramine may increase the central nervous system depressant CNS depressant activities of Fluoxetine"
                    },
                    {
                        "drugbank-id": "DB14881",
                        "description": "The risk or severity of hypotension sedation death somnolence and respiratory depression can be increased when Mepyramine is combined with Oliceridine"
                    }
                ]
            }
        },
        "revision_date": "2023-05-14"
    }
}